[go: up one dir, main page]

JPH06247928A - Production of alpha, beta-substituted cyclopentanone derivative - Google Patents

Production of alpha, beta-substituted cyclopentanone derivative

Info

Publication number
JPH06247928A
JPH06247928A JP50A JP5483393A JPH06247928A JP H06247928 A JPH06247928 A JP H06247928A JP 50 A JP50 A JP 50A JP 5483393 A JP5483393 A JP 5483393A JP H06247928 A JPH06247928 A JP H06247928A
Authority
JP
Japan
Prior art keywords
group
carbon atoms
compound
hydrogen atom
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP50A
Other languages
Japanese (ja)
Other versions
JP3304477B2 (en
Inventor
Fumie Satou
史衛 佐藤
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nissan Chemical Corp
Original Assignee
Nissan Chemical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nissan Chemical Corp filed Critical Nissan Chemical Corp
Priority to JP05483393A priority Critical patent/JP3304477B2/en
Publication of JPH06247928A publication Critical patent/JPH06247928A/en
Application granted granted Critical
Publication of JP3304477B2 publication Critical patent/JP3304477B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

PURPOSE:To obtain the subject compound as an intermediate for prostaglandins in a high yield and through short steps under neutral and mild conditions without troubles such as preparing unstable anionic reagent (s). CONSTITUTION:The compound of formula V can be obtained by reaction, in the presence of a radical generator, between (A) a substituted cyclopentanone derivative of formula {X is (alphaOZ, beta-H) or (alpha-H, beta-OZ) (Z is OH-protecting group), Y is (-alpha-H, beta-R) or (alpha-R, beta-H) [ R is formula II (T is CH2CH2 or CH=CH; (j) and (k) each 0-2; R<0> is H, alkyl or alkoxy; R<1> is alkyl, cycloalkyl, alkenyl, alkynyl, phenyl, phenoxy, etc.)]} and (B) a compound of formula III [A is halogen or formula IV (R<x> is H, alkyl, aryl, etc.); R<2>-R<8> are each H, alkyl or alkoxyl; R<9> is H, alkyl, halogen, CN, NH2, etc.; U is T, CidenticalC, phenylene, etc.; (l) is 1-7; (m), (p) and (r) are each 0 or 1; (n), (q) and (s) are each 0-5; X<1> and X<2> are each 0 or S; Z<1> is CN, OH, H, halogen, etc.], followed by, if desired, hydrolysis.

Description

【発明の詳細な説明】Detailed Description of the Invention

【0001】[0001]

【産業上の利用分野】本発明は、医農薬品の中間体、特
にプロスタグランジン類の合成中間体として有用なα,
β−置換シクロペンタノン誘導体の製造法に関する。
TECHNICAL FIELD The present invention relates to α, which is useful as an intermediate for medical and agricultural chemicals, particularly as a synthetic intermediate for prostaglandins.
The present invention relates to a method for producing a β-substituted cyclopentanone derivative.

【0002】[0002]

【従来の技術及び発明が解決しようとする課題】α,β
−置換シクロペンタノン誘導体類は医農薬中間体として
注目されており、特に強力な生理活性を有するプロスタ
グランジン類の合成中間体として有用である。従来、プ
ロスタグランジン類を製造する反応の1つとして、次式
で表わされる共役付加反応によるプロスタグランジンF
2 αの合成法が知られている〔ジー・スターク等、ジャ
ーナル・アメリカン・ケミカル・ソサイヤティ(J.A
m.Chem.Soc.)、97巻、4745,626
0頁、(1975年)〕。
PRIOR ART AND PROBLEM TO BE SOLVED BY THE INVENTION α, β
-Substituted cyclopentanone derivatives have attracted attention as intermediates for medical and agricultural chemicals, and are particularly useful as synthetic intermediates for prostaglandins having strong physiological activity. Conventionally, as one of the reactions for producing prostaglandins, a prostaglandin F by a conjugate addition reaction represented by the following formula
2 The synthesis method of α is known [J. Stark et al., Journal American Chemical Society (JA
m. Chem. Soc. ), 97, 4745, 626
0, (1975)].

【0003】[0003]

【化6】 [Chemical 6]

【0004】前記プロスタグランジンF2αの合成法は
化合物(IV)からの収率が高く、しかも共役付加の試薬
を選択することによりα鎖部分を自由に変更することが
できる特徴を有している。しかしながら、従来知られて
いる共役付加試薬は、置換基としてCO212、CN、
OCOR13(但し、式中R12及びR13は互いに同一又
は異種の炭素数1〜6のアルキル基を示す)などの有機
金属試剤と反応し易い基を含むことができず、このため
このような置換基は変換により形成されていた。例え
ば、上記プロスタグランジンF2αの合成においても−
CH(CH3)OC25基を離脱させてアルコールに変換
し、これを更に有毒なクロム系酸化剤で酸化することに
よってカルボン酸に誘導するという迂遠な方法を用いて
おり、工業的製法としては種々問題があった。
The method for synthesizing the prostaglandin F 2 α is characterized in that the yield from the compound (IV) is high, and the α chain portion can be freely changed by selecting a reagent for conjugate addition. ing. However, the conventionally known conjugated addition reagents include CO 2 R 12 , CN, and
OCOR 13 (wherein R 12 and R 13 represent the same or different alkyl groups having 1 to 6 carbon atoms) or the like and cannot contain a group that easily reacts with an organometallic agent, and thus, Such substituents were formed by conversion. For example, also in the synthesis of the above prostaglandin F 2 α,
The CH (CH 3 ) OC 2 H 5 group is released to convert it to an alcohol, and this is further oxidized with a toxic chromium-based oxidant to induce a carboxylic acid. There were various problems.

【0005】一方、上述の従来直接導入できなかった置
換基を有し、かかる置換基を直接導入し得る共役付加試
剤を用いる方法として有機亜鉛試剤を用いる方法がある
〔佐藤ら、特開平02−184487号〕。
On the other hand, there is a method of using an organozinc reagent as a method of using a conjugated addition reagent having a substituent which cannot be directly introduced as described above and which can directly introduce such a substituent [Sato et al., JP-A-02- 184487].

【0006】[0006]

【化7】 [Chemical 7]

【0007】上述の方法は、前記ジー・スタークの方法
の問題点の多くを解決する有力な方法である。しかしな
がら有機亜鉛試剤の反応もアニオン反応であるため、置
換基としてOH、COOHのような、反応性の水素原子
を持つものは含むことができない。又、どちらの方法
も、アニオン反応のため部分構造として
The method described above is a powerful method that solves many of the problems of the G-Stark method. However, since the reaction of the organozinc reagent is also an anion reaction, it is not possible to include a compound having a reactive hydrogen atom such as OH and COOH as a substituent. Also, both methods have partial structures due to anion reaction.

【0008】[0008]

【化8】 [Chemical 8]

【0009】のようにβ脱離をし易いもの、A substance which easily causes β-elimination, such as

【0010】[0010]

【化9】 [Chemical 9]

【0011】のようにマイケル付加し易いもの、A material such as Michael which is easy to add,

【0012】[0012]

【化10】 [Chemical 10]

【0013】のようにアレンになり易いものを含む場合
には、試剤の調製ができないか、副反応を起こし易い。
更に水分や酸素の混入を防ぐ必要があり、又、一般に極
低温を必要とする場合が多く、試剤の調製には特殊なノ
ウハウがあり、失敗することもある。
In the case of containing a compound which is likely to be an allene as described above, the reagent cannot be prepared or a side reaction is likely to occur.
Furthermore, it is necessary to prevent mixing of water and oxygen, and in general, extremely low temperatures are required in many cases, and there are special know-hows for preparation of reagents, which may lead to failure.

【0014】本発明は、上記事情に鑑みなされたもの
で、プロスタグランジン類の中間体として有用であり、
工業的に有利にプロスタグランジン類に誘導することが
できるα,β−シクロペンタノン誘導体を不安定なアニ
オン性の反応試剤を用いる等の不都合なく短工程で効率
よく製造する方法を提供することを目的とする。
The present invention has been made in view of the above circumstances, and is useful as an intermediate for prostaglandins,
PROBLEM TO BE SOLVED: To provide a method for efficiently producing an α, β-cyclopentanone derivative which can be industrially advantageously induced into a prostaglandin in a short process without inconvenience such as using an unstable anionic reaction reagent. With the goal.

【0015】[0015]

【課題を解決するための手段及び作用】本発明者らは、
上記目的を達成するため鋭意検討を行なった結果、下記
一般式〔I〕
Means and Actions for Solving the Problems The present inventors have
As a result of intensive studies to achieve the above object, the following general formula [I]

【0016】[0016]

【化11】 [Chemical 11]

【0017】〔但し、式中Xは(α−OZ,β−H)又
は(α−H,β−OZ)を示し、Zは水酸基の保護基を
示す。又、Yは(α−H,β−R)又は(α−R,β−
H)を示し、Rは
[Wherein, X represents (α-OZ, β-H) or (α-H, β-OZ), and Z represents a hydroxyl-protecting group. Y is (α-H, β-R) or (α-R, β-
H) and R is

【0018】[0018]

【化12】 [Chemical 12]

【0019】で示される基で、TはCH2CH2又はCH
=CHより選ばれる基を、j及びkはそれぞれ独立に
0、1又は2の整数を、R0は(2−k)個の水素原
子、炭素数1〜4のアルキル基又は炭素数1〜4のアル
コキシ基を、R1は炭素数1〜10のアルキル基、炭素
数3〜8のシクロアルキル基、炭素数2〜10のアルケ
ニル基、炭素数2〜10のアルキニル基、フェニル基、
フェノキシ基、「ハロゲン原子、トリフルオロメチル
基、炭素数1〜6のアルキル基、炭素数1〜6のアルコ
キシ基」で置換されたフェニル基若しくはフェノキシ
基、あるいは−B−D(Bは炭素数1〜4のアルキレン
基を、Dはフェニル基、フェノキシ基、「ハロゲン原
子、トリフルオロメチル基、炭素数1〜6のアルキル
基、炭素数1〜6のアルコキシ基、フェニル基若しくは
フェノキシ基」で置換されたフェニル基若しくはフェノ
キシ基又は炭素数5〜7のシクロアルキル基を示す。)
で表される基を示し、Z′は上記Zと同種又は異種の水
酸基の保護基を示す。〕で表される置換シクロペンタノ
ン誘導体と、一般式〔II〕 A(CR23)l1 m(CR45)np(CR67)q2 r(CR89)s1 〔II〕 〔但し、式中、Aはハロゲン原子又は
In the group represented by, T is CH 2 CH 2 or CH
A group selected from ═CH, j and k each independently represent an integer of 0, 1 or 2, and R 0 represents (2-k) hydrogen atoms, an alkyl group having 1 to 4 carbon atoms or 1 to 2 carbon atoms. 4 alkoxy group, R 1 is an alkyl group having 1 to 10 carbon atoms, a cycloalkyl group having 3 to 8 carbon atoms, an alkenyl group having 2 to 10 carbon atoms, an alkynyl group having 2 to 10 carbon atoms, a phenyl group,
Phenoxy group, phenyl group or phenoxy group substituted by "halogen atom, trifluoromethyl group, alkyl group having 1 to 6 carbon atoms, alkoxy group having 1 to 6 carbon atoms", or -BD (B is the number of carbon atoms 1 to 4 is an alkylene group, D is a phenyl group, a phenoxy group, "a halogen atom, a trifluoromethyl group, an alkyl group having 1 to 6 carbon atoms, an alkoxy group having 1 to 6 carbon atoms, a phenyl group or a phenoxy group". It represents a substituted phenyl group or phenoxy group or a cycloalkyl group having 5 to 7 carbon atoms.)
And Z'represents a protective group for a hydroxyl group which is the same as or different from Z described above. ] And substituted cyclopentanone derivative represented by the general formula [II] A (CR 2 R 3) l X 1 m (CR 4 R 5) n U p (CR 6 R 7) q X 2 r (CR 8 R 9 ) s Z 1 [II] [wherein A is a halogen atom or

【0020】[0020]

【化13】 [Chemical 13]

【0021】(RXは水素原子、炭素数1〜9のアルキ
ル基、アラルキル基又はアリール基を表す。)を示し、
2、R3、R4、R5、R6、R7及びR8はそれぞれ独立
に水素原子、炭素数1〜4のアルキル基又は炭素数1〜
4のアルコキシ基を示し、R9は水素原子、炭素数1〜
6のアルキル基、炭素数1〜6のアルコキシ基、ハロゲ
ン原子、CN、NH2、OH又は−COORa(Raは水
素原子、炭素数1〜6のアルキル基又は炭素数2〜6の
アルケニル基を示す)を、UはCH2CH2 、CH=C
H、C≡C、C=C=C又はフェニレン基より選ばれる
基を示し、lは1〜7の整数、m、p及びrはそれぞれ
0又は1の整数、n、q及びsはそれぞれ0〜5の整数
を示す。X1及びX2はそれぞれ酸素原子又はイオウ原子
を示し、Z1はCO2y、CN、OH、OCORz、CO
NRbc(Rb及びRcはそれぞれ水素原子、炭素数1〜
6のアルキル基、炭素数1〜6のアルコキシ基、ベンジ
ル基又はフェニル基を示す。)、水素原子、ハロゲン原
子、又は置換若しくは無置換の芳香族基より選ばれる基
を示し、Ry及びRzはそれぞれ水素原子、炭素数1〜6
のアルキル基又は炭素数2〜6のアルケニル基を示
す。〕で表わされる有機ラジカル前駆体とを、水素化ス
ズ、及びアゾビスイソブチロニトリル又はトリアルキル
ボラン、亜鉛−銅錯体等のラジカル発生剤の存在下で反
応させ、必要により加水分解を施すことにより、上記有
機ラジカル前駆体中に、水酸基、カルボキシル基、β−
オキサ基、α,β−不飽和エステル基、β−三重結合と
いった基が含まれていても支障なくこれらの基を直接導
入することができ、又クロム系酸化剤等の有毒な反応試
剤を用いることなく、短工程かつ高収率に下記一般式
〔III〕
(R X represents a hydrogen atom, an alkyl group having 1 to 9 carbon atoms, an aralkyl group or an aryl group),
R < 2 >, R < 3 >, R < 4 >, R < 5 >, R < 6 >, R < 7 > and R <8> are each independently a hydrogen atom, an alkyl group having 1 to 4 carbon atoms or 1 to 4 carbon atoms.
4 is an alkoxy group, R 9 is a hydrogen atom and has 1 to 1 carbon atoms.
An alkyl group having 6 carbon atoms, an alkoxy group having 1 to 6 carbon atoms, a halogen atom, CN, NH 2 , OH or —COOR a ( Ra is a hydrogen atom, an alkyl group having 1 to 6 carbon atoms or an alkenyl having 2 to 6 carbon atoms). Group is shown), U is CH 2 CH 2 , CH═C
H, C≡C, C = C = C or a group selected from phenylene groups, l is an integer of 1 to 7, m, p and r are each an integer of 0 or 1, and n, q and s are each 0. Indicates an integer of ˜5. X 1 and X 2 each represent an oxygen atom or a sulfur atom, and Z 1 is CO 2 R y , CN, OH, OCOR z or CO.
NR b R c (R b and R c are each a hydrogen atom and a carbon number of 1 to
6 represents an alkyl group having 6 carbon atoms, an alkoxy group having 1 to 6 carbon atoms, a benzyl group or a phenyl group. ), A hydrogen atom, a halogen atom, or a group selected from a substituted or unsubstituted aromatic group, wherein R y and R z are a hydrogen atom and a carbon number of 1 to 6, respectively.
Represents an alkyl group or an alkenyl group having 2 to 6 carbon atoms. ] With an organic radical precursor represented by, in the presence of a radical generator such as tin hydride and azobisisobutyronitrile or trialkylborane, zinc-copper complex, and subject to hydrolysis if necessary. Therefore, in the organic radical precursor, a hydroxyl group, a carboxyl group, β-
Even if a group such as an oxa group, an α, β-unsaturated ester group or a β-triple bond is contained, these groups can be directly introduced without any trouble, and a toxic reaction reagent such as a chromium-based oxidizing agent is used. Without the following general formula [III]

【0022】[0022]

【化14】 [Chemical 14]

【0023】〔但し、式中Wは(α−OQ,β−H)又
は(α−H,β−OQ)を示し、Qは水素原子又はZと
同じ水酸基の保護基を示す。又、Vは(α−H,β−
R)又は(α−R,β−H)を示し、Rは
[Wherein, W represents (α-OQ, β-H) or (α-H, β-OQ), and Q represents a hydrogen atom or a protective group for the same hydroxyl group as Z.] Also, V is (α-H, β-
R) or (α-R, β-H), and R is

【0024】[0024]

【化15】 [Chemical 15]

【0025】で示される基で、T、R0、j及びkは前
記と同じ意味を示し、Q′は水素原子又はZ′と同じ水
酸基の保護基を示す。又、X1、X2、U、R2、R3、R
4、R5、R6、R7、R8、R9、Z1、l、m、n、p、
q、r及びsは前記と同じ意味を示す。〕で表わされる
α,β−置換シクロペンタノン誘導体が得られることを
知見し、本発明を完成したものである。
In the group represented by, T, R 0 , j and k have the same meanings as described above, and Q'represents a hydrogen atom or the same hydroxyl-protecting group as Z '. Also, X 1 , X 2 , U, R 2 , R 3 , R
4 , R 5 , R 6 , R 7 , R 8 , R 9 , Z 1 , l, m, n, p,
q, r and s have the same meanings as described above. The present invention has been completed by finding that an α, β-substituted cyclopentanone derivative represented by the following formula can be obtained.

【0026】従って、本発明は、上記〔I〕式の置換シ
クロペンタノンと上記〔II〕式の有機ラジカル前駆体と
を、ラジカル発生剤の存在下で反応させ、所望により加
水分解することを特徴とする上記〔III〕式で表わされ
るα,β−置換シクロペンタノン誘導体の製造法を提供
する。
Therefore, according to the present invention, the substituted cyclopentanone represented by the above formula [I] and the organic radical precursor represented by the above formula [II] are reacted in the presence of a radical generator and optionally hydrolyzed. A method for producing an α, β-substituted cyclopentanone derivative represented by the above formula [III] is provided.

【0027】以下、本発明について更に詳しく説明す
る。本発明のα,β−置換シクロペンタノン誘導体の製
造法において、第1の出発原料である一般式
The present invention will be described in more detail below. In the method for producing an α, β-substituted cyclopentanone derivative of the present invention, the general formula which is the first starting material is

【0028】[0028]

【化16】 [Chemical 16]

【0029】で表わされる置換シクロペンタノン誘導体
は既知の化合物であり、特開平2−128号公報に記載
された方法等、種々の方法により製造することができ
る。ここで、上記一般式〔I〕において、X及びYは前
記した通りであり、Xは(α−OZ,β−H)又は(α
−H,β−OZ)、Yは(α−H,β−R)又は(α−
R,β−H)を示し、Zは水酸基の保護基、Rは
The substituted cyclopentanone derivative represented by is a known compound and can be produced by various methods such as the method described in JP-A-2-128. Here, in the general formula [I], X and Y are as described above, and X is (α-OZ, β-H) or (α
-H, β-OZ), Y is (α-H, β-R) or (α-
R, β-H), Z is a hydroxyl protecting group, and R is

【0030】[0030]

【化17】 [Chemical 17]

【0031】で示される基で、TはCH2CH2又はCH
=CHより選ばれる基を、j及びkはそれぞれ独立に
0、1又は2の整数を、R0は(2−k)個の水素原
子、炭素数1〜4のアルキル基又は炭素数1〜4のアル
コキシ基を、R1は炭素数1〜10のアルキル基、炭素
数3〜8のシクロアルキル基、炭素数2〜10のアルケ
ニル基、炭素数2〜10のアルキニル基、フェニル基、
フェノキシ基、「ハロゲン原子、トリフルオロメチル
基、炭素数1〜6のアルキル基、炭素数1〜6のアルコ
キシ基」で置換されたフェニル基若しくはフェノキシ
基、あるいは−B−D(Bは炭素数1〜4のアルキレン
基を、Dはフェニル基、フェノキシ基、「ハロゲン原
子、トリフルオロメチル基、炭素数1〜6のアルキル
基、炭素数1〜6のアルコキシ基、フェニル基若しくは
フェノキシ基」で置換されたフェニル基若しくはフェノ
キシ基又は炭素数5〜7のシクロアルキル基を示す。)
で表される基を示し、Z′は水酸基の保護基であるが、
この場合、Z,Z′の水酸基の保護基としては、トリア
ルキルシリル基(例えばトリメチルシリル基、t−ブチ
ルジメチルシリル基)、アルコキシアルキル基(例えば
メトキシメチル基)、アラルキルオキシアルキル基(例
えばベンジルオキシメチル基)、トリチル基、更にはテ
トラヒドロピラニル(THP)基等が挙げられ、Zと
Z′とは互いに同一でも異なっていてもよい。kが2の
場合、2つのZ′基が一緒になって、アルキレン基(例
えば、エチレン基、1,1,2,2−テトラメチルエチ
レン基)であっても良い。又、
In the group represented by, T is CH 2 CH 2 or CH
A group selected from ═CH, j and k each independently represent an integer of 0, 1 or 2, and R 0 represents (2-k) hydrogen atoms, an alkyl group having 1 to 4 carbon atoms or 1 to 2 carbon atoms. 4 alkoxy group, R 1 is an alkyl group having 1 to 10 carbon atoms, a cycloalkyl group having 3 to 8 carbon atoms, an alkenyl group having 2 to 10 carbon atoms, an alkynyl group having 2 to 10 carbon atoms, a phenyl group,
Phenoxy group, phenyl group or phenoxy group substituted by "halogen atom, trifluoromethyl group, alkyl group having 1 to 6 carbon atoms, alkoxy group having 1 to 6 carbon atoms", or -BD (B is the number of carbon atoms 1 to 4 is an alkylene group, D is a phenyl group, a phenoxy group, "a halogen atom, a trifluoromethyl group, an alkyl group having 1 to 6 carbon atoms, an alkoxy group having 1 to 6 carbon atoms, a phenyl group or a phenoxy group". It represents a substituted phenyl group or phenoxy group or a cycloalkyl group having 5 to 7 carbon atoms.)
And Z'is a protective group for a hydroxyl group,
In this case, the protective groups for the hydroxyl groups of Z and Z ′ include trialkylsilyl groups (eg trimethylsilyl group, t-butyldimethylsilyl group), alkoxyalkyl groups (eg methoxymethyl group), aralkyloxyalkyl groups (eg benzyloxy group). Examples thereof include a methyl group), a trityl group, and a tetrahydropyranyl (THP) group. Z and Z ′ may be the same or different from each other. When k is 2, two Z'groups may be combined to form an alkylene group (eg, ethylene group, 1,1,2,2-tetramethylethylene group). or,

【0032】[0032]

【化18】 [Chemical 18]

【0033】のR1としては炭素数1〜10であるもの
が好ましく、具体的にはメチル基、n−プロピル基、n
−ペンチル基、フェノキシメチル基、3−(t−ブチル
ジメチルシリルオキシ)−2−ヘキシル基等の置換若し
くは未置換のアルキル基;ビニル基、アリル基、2−ペ
ンテン−1−イル基、4−フェニル−2−ブテン−1−
イル基等の置換若しくは未置換のアルケニル基;1−ブ
チニル基、1−ヘキシニル基、2−ペンチニル基、5−
(エトキシエチルオキシ)−2−ペンチン−1−イル基
等の置換若しくは未置換のアルキニル基;フェニル基、
3−トリフロロメチルフェニル基等の置換若しくは未置
換のアリール基などが挙げられる。
R 1 is preferably one having 1 to 10 carbon atoms, specifically, methyl group, n-propyl group, n
-Substituted or unsubstituted alkyl groups such as pentyl group, phenoxymethyl group, 3- (t-butyldimethylsilyloxy) -2-hexyl group; vinyl group, allyl group, 2-penten-1-yl group, 4- Phenyl-2-butene-1-
A substituted or unsubstituted alkenyl group such as an yl group; 1-butynyl group, 1-hexynyl group, 2-pentynyl group, 5-
A substituted or unsubstituted alkynyl group such as (ethoxyethyloxy) -2-pentyn-1-yl group; a phenyl group,
Examples thereof include substituted or unsubstituted aryl groups such as 3-trifluoromethylphenyl group.

【0034】この場合、プロスタグランジン類の中間体
を得るに際してはRの
In this case, when the intermediate of prostaglandins is obtained, R

【0035】[0035]

【化19】 [Chemical 19]

【0036】で示される基がThe group represented by

【0037】[0037]

【化20】 [Chemical 20]

【0038】(但し、式中Z″は水酸基の保護基を示
し、前述の水酸基の保護基Zと同一であっても異なって
いてもよい。
(In the formula, Z ″ represents a hydroxyl-protecting group and may be the same as or different from the above-mentioned hydroxyl-protecting group Z.

【0039】[0039]

【化21】 [Chemical 21]

【0040】は一重結合又は二重結合を示し、R10は炭
素数1〜10のアルキル基、炭素数3〜8のシクロアル
キル基、炭素数2〜10のアルケニル基、炭素数2〜1
0のアルキニル基、フェニル基、フェノキシ基、「ハロ
ゲン原子、トリフルオロメチル基、炭素数1〜6のアル
キル基、炭素数1〜6のアルコキシ基」で置換されたフ
ェニル基若しくはフェノキシ基、あるいは−B−D(B
は炭素数1〜4のアルキレン基を、Dはフェニル基、フ
ェノキシ基、「ハロゲン原子、トリフルオロメチル基、
炭素数1〜6のアルキル基、炭素数1〜6のアルコキシ
基、フェニル基若しくはフェノキシ基」で置換されたフ
ェニル基若しくはフェノキシ基又は炭素数5〜7のシク
ロアルキル基を、R4は、水素原子、メチル基、エチル
基、メトキシ基、エトキシ基等を示す。)で表わされる
基であることが好ましい。なお、R10としては、メチル
基、エチル基、n−プロピル基、i−プロピル基、n−
ブチル基、i−ブチル基、t−ブチル基、アミル基、ヘ
キシル基、ヘプチル基、オクチル基、ノニル基、デシル
基、2−メチルヘキシル基、2−メチル−2−ヘキシル
基、2−ヘキシル基、シクロペンチル基、シクロヘキシ
ル基、シクロヘキシルメチル基、ヘキサ−4−イン−2
−イル基、ヘプタ−4−イン−2−イル基、2,6−ジ
メチル−ヘプタ−5−エン−1−イル基、ペンタ−1−
エン−1−イル基、ペンタ−2−エン−1−イル基、ヘ
キサ−1−エン−2−イル基、3−エトキシ−2−メチ
ル−プロパン−2−イル基、エトキシエチル基、5−メ
トキシヘキシル基、2−(トリメチルシリルオキシ)−
2−ヘキシル基、ハロゲン化メチル基、ハロゲン化n−
ブチル基、ハロゲン化n−ペンチル基、ハロゲン化ノニ
ル基、フェニル基、ベンジル基、ハロゲン化フェニル
基、n−ペンチルオキシメチル基、1−エトキシ−2−
メチル−プロパン−2−イル基、フェノキシメチル基、
ベンジロキシメチル基、p−クロルフェノキシメチル
基、2−フェニルエチル基、ベンジロキシエチル基、p
−フルオロフェノキシメチル基、フェニルアセチレニル
基、m−クロルフェノキシメチル基、m−トリフルオロ
メチル−フェノキシメチル基、1−ブチル−シクロプロ
ピル基、3−エチル−シクロペンチル基、ベンゾチオフ
ェン−5−イル基、2−オクテニル基、3−メトキシカ
ルボニルプロピル基、ビニル基等が挙げられ、Z″とし
ては、前記Zと同様の保護基を例示することができる。
Represents a single bond or a double bond, and R 10 represents an alkyl group having 1 to 10 carbon atoms, a cycloalkyl group having 3 to 8 carbon atoms, an alkenyl group having 2 to 10 carbon atoms, and 2-1 to 2 carbon atoms.
0 alkynyl group, phenyl group, phenoxy group, phenyl group or phenoxy group substituted by "halogen atom, trifluoromethyl group, alkyl group having 1 to 6 carbon atoms, alkoxy group having 1 to 6 carbon atoms", or- BD (B
Is an alkylene group having 1 to 4 carbon atoms, D is a phenyl group, a phenoxy group, a "halogen atom, a trifluoromethyl group,
A phenyl group or a phenoxy group substituted with an alkyl group having 1 to 6 carbon atoms, an alkoxy group having 1 to 6 carbon atoms, a phenyl group or a phenoxy group or a cycloalkyl group having 5 to 7 carbon atoms, and R 4 is hydrogen. An atom, a methyl group, an ethyl group, a methoxy group, an ethoxy group and the like are shown. It is preferable that it is a group represented by these. R 10 is a methyl group, an ethyl group, an n-propyl group, an i-propyl group, an n-
Butyl group, i-butyl group, t-butyl group, amyl group, hexyl group, heptyl group, octyl group, nonyl group, decyl group, 2-methylhexyl group, 2-methyl-2-hexyl group, 2-hexyl group , Cyclopentyl group, cyclohexyl group, cyclohexylmethyl group, hexa-4-yn-2
-Yl group, hepta-4-in-2-yl group, 2,6-dimethyl-hepta-5-en-1-yl group, penta-1-
En-1-yl group, penta-2-en-1-yl group, hexa-1-en-2-yl group, 3-ethoxy-2-methyl-propan-2-yl group, ethoxyethyl group, 5- Methoxyhexyl group, 2- (trimethylsilyloxy)-
2-hexyl group, halogenated methyl group, halogenated n-
Butyl group, halogenated n-pentyl group, halogenated nonyl group, phenyl group, benzyl group, halogenated phenyl group, n-pentyloxymethyl group, 1-ethoxy-2-
Methyl-propan-2-yl group, phenoxymethyl group,
Benzyloxymethyl group, p-chlorphenoxymethyl group, 2-phenylethyl group, benzyloxyethyl group, p
-Fluorophenoxymethyl group, phenylacetylenyl group, m-chlorphenoxymethyl group, m-trifluoromethyl-phenoxymethyl group, 1-butyl-cyclopropyl group, 3-ethyl-cyclopentyl group, benzothiophen-5-yl Group, a 2-octenyl group, a 3-methoxycarbonylpropyl group, a vinyl group, and the like, and examples of Z ″ include the same protecting groups as the above Z.

【0041】次に、本発明製造法の第2出発原料である
有機ラジカル前駆体は、一般式〔II〕 A(CR23)l1 m(CR45)np(CR67)q2 r(CR89)s1 〔II〕 で表わされるもので、式〔II〕中のA、U、l、m、
n、p、q、r、s、R2、R3、R4、R5、R6、R7
8、R9、X1、X2及びZ1は前記の通りであり、Aは
ハロゲン原子、又は
Next, the organic radical precursor, which is the second starting material in the production method of the present invention, has the general formula [II] A (CR 2 R 3 ) l X 1 m (CR 4 R 5 ) n Up (CR 6 R 7 ) q X 2 r (CR 8 R 9 ) s Z 1 [II], wherein A, U, l, m in the formula [II],
n, p, q, r, s, R 2 , R 3 , R 4 , R 5 , R 6 , R 7 ,
R 8 , R 9 , X 1 , X 2 and Z 1 are as described above, A is a halogen atom, or

【0042】[0042]

【化22】 [Chemical formula 22]

【0043】(RXは水素原子、炭素数1〜9のアルキ
ル基、アラルキル基又はアリール基を表す。)を、Uは
CH2CH2 、CH=CH、C≡C、C=C=C又はフ
ェニレン基より選ばれる基を示し、lは1〜7の整数、
m、p及びrはそれぞれ0又は1の整数、n、q及びs
はそれぞれ0〜5の整数を示す。X1及びX2はそれぞれ
酸素原子又はイオウ原子を示し、Z1はCO2y、C
N、OH、OCORz、CONRbc(Rb及びRcはそ
れぞれ水素原子、炭素数1〜6のアルキル基、炭素数1
〜6のアルコキシ基、ベンジル基又はフェニル基を示
す。)、水素原子、ハロゲン原子、又は置換若しくは無
置換の芳香族基より選ばれる基を示し、Ry及びRzはそ
れぞれ水素原子、炭素数1〜6のアルキル基又は炭素数
2〜6のアルケニル基を示す。この場合、式中のR2
9及びZ1を除いた炭素原子数は合計で1〜10の範囲
内にはいるものとすることが好ましい。
(R X represents a hydrogen atom, an alkyl group having 1 to 9 carbon atoms, an aralkyl group or an aryl group), and U is CH 2 CH 2 , CH = CH, C≡C, C = C = C. Or a group selected from a phenylene group, l is an integer of 1 to 7,
m, p and r are integers of 0 or 1 respectively, n, q and s
Each represents an integer of 0 to 5. X 1 and X 2 each represent an oxygen atom or a sulfur atom, Z 1 is CO 2 R y , C
N, OH, OCOR z , CONR b R c (R b and R c are each a hydrogen atom, an alkyl group having 1 to 6 carbon atoms, and 1 carbon atom)
6 represents an alkoxy group, a benzyl group or a phenyl group. ), A hydrogen atom, a halogen atom, or a group selected from a substituted or unsubstituted aromatic group, R y and R z are each a hydrogen atom, an alkyl group having 1 to 6 carbon atoms or an alkenyl having 2 to 6 carbon atoms. Indicates a group. In this case, R 2 in the formula
The total number of carbon atoms excluding R 9 and Z 1 is preferably within the range of 1 to 10.

【0044】Z1で示された置換基のうち置換若しくは
無置換の芳香族基としては、「ハロゲン原子、トリフル
オロメチル基、炭素数1〜6のアルキル基、炭素数1〜
6のアルコキシ基、CO2d、CN、OH、OCORe
又はCONRfg(Rd及びReはそれぞれ水素原子、炭
素数1〜6のアルキル基又は炭素数2〜6のアルケニル
基を示す。Rf及びRgはそれぞれ水素原子、炭素数1〜
6のアルキル基、炭素数1〜6のアルコキシ基、ベンジ
ル基又はフェニル基を示す。)」で置換されていてもよ
いフェニル基、ナフチル基、チエニル基、フリル基、ピ
ロリル基、イミダゾリル基、ピラゾリル基、イソチアゾ
リル基、イソオキサゾリル基、ピリジル基、ピラジニル
基、ピリミジニル基、ピリダジニル基、インドリル基、
キノリル基、キノキサリニル基等を挙げることができ
る。
The substituted or unsubstituted aromatic group among the substituents represented by Z 1 includes "a halogen atom, a trifluoromethyl group, an alkyl group having 1 to 6 carbon atoms, and 1 to 6 carbon atoms".
6 alkoxy groups, CO 2 R d , CN, OH, OCOR e
Or CONR f R g (R d and R e are each a hydrogen atom, an alkyl group having 1 to 6 carbon atoms or an alkenyl group having 2 to 6 carbon atoms. R f and R g are each a hydrogen atom and 1 to 6 carbon atoms.
6 represents an alkyl group having 6 carbon atoms, an alkoxy group having 1 to 6 carbon atoms, a benzyl group or a phenyl group. ) ", Which may be substituted with phenyl group, naphthyl group, thienyl group, furyl group, pyrrolyl group, imidazolyl group, pyrazolyl group, isothiazolyl group, isoxazolyl group, pyridyl group, pyrazinyl group, pyrimidinyl group, pyridazinyl group, indolyl group ,
Examples thereof include a quinolyl group and a quinoxalinyl group.

【0045】Aのハロゲン原子としては、塩素原子、臭
素原子又はヨウ素原子であり、
The halogen atom of A is a chlorine atom, a bromine atom or an iodine atom,

【0046】[0046]

【化23】 [Chemical formula 23]

【0047】中のRXとしては、水素原子、メチル、エ
チル、プロピル、ブチル、t−ブチル、オクチル等のア
ルキル基、ベンジル基等のアラルキル基、フェニル基等
のアリール基が挙げられる。
Examples of R X include a hydrogen atom, an alkyl group such as methyl, ethyl, propyl, butyl, t-butyl and octyl, an aralkyl group such as a benzyl group, and an aryl group such as a phenyl group.

【0048】上記式〔II〕の有機ラジカル前駆体として
具体的には、これらの式をAR5と表わした場合におい
て、R5がメチル基、エチル基、n−プロピル基、n−
ブチル基、t−ブチル基、
Concretely, as the organic radical precursor of the above formula [II], when these formulas are represented by AR 5 , R 5 is methyl group, ethyl group, n-propyl group, n-
Butyl group, t-butyl group,

【0049】[0049]

【化24】 [Chemical formula 24]

【0050】[0050]

【化25】 [Chemical 25]

【0051】[0051]

【化26】 [Chemical formula 26]

【0052】等であるものが挙げられる。なお、上記式
iPrはi−プロピル基、nBuはn−ブチル基、t
uはターシャーリーブチル基である。
And the like. In the above formula, i Pr is i-propyl group, n Bu is n-butyl group, t B
u is a tert-butyl group.

【0053】AがA is

【0054】[0054]

【化27】 [Chemical 27]

【0055】である化合物は、対応するアルコール体
(R5OH)から公知の方法(例えば、D.H.R.B
artonら、Synthesis,1981,74
3.)に従い合成することができる。
The compound of formula (I) can be prepared by a known method (for example, DHRB) from the corresponding alcohol (R 5 OH).
arton et al., Synthesis, 1981 , 74.
3. ).

【0056】[0056]

【化28】 [Chemical 28]

【0057】本発明の製造法は、上記一般式〔I〕の置
換シクロペンタノン誘導体と一般式〔II〕の有機ラジカ
ル前駆体とをラジカル発生剤の存在下で反応させ、必要
に応じて加水分解することにより、一般式〔III〕
In the production method of the present invention, the substituted cyclopentanone derivative represented by the general formula [I] is reacted with the organic radical precursor represented by the general formula [II] in the presence of a radical generator, and optionally hydrolyzed. By decomposing, the general formula [III]

【0058】[0058]

【化29】 [Chemical 29]

【0059】で示されるα,β−置換シクロペンタノン
誘導体を合成するものである。ここで、上記一般式〔II
I〕において、W、V、U、X1、X2、R2、R3、R4
5、R6、R7、R8、R9、Z1、l、m、n、p、q、
r、sは前記の通りであり、Wは(α−OQ,β−H)
又は(α−H,β−OQ)、Vは(α−H,β−R)又
は(α−R,β−H)を示し、Qは水素原子又はZと同
じ水酸基の保護基、Rは
An α, β-substituted cyclopentanone derivative represented by is synthesized. Here, the above general formula [II
I], W, V, U, X 1 , X 2 , R 2 , R 3 , R 4 ,
R 5 , R 6 , R 7 , R 8 , R 9 , Z 1 , l, m, n, p, q,
r and s are as described above, and W is (α-OQ, β-H).
Or (α-H, β-OQ), V represents (α-H, β-R) or (α-R, β-H), Q is a hydrogen atom or a protective group of the same hydroxyl group as Z, and R is

【0060】[0060]

【化30】 [Chemical 30]

【0061】で示される基で、TはCH2CH2又はCH
=CHより選ばれる基を、j及びkはそれぞれ独立に
0、1又は2の整数を、R0は(2−k)個の水素原
子、炭素数1〜4のアルキル基又は炭素数1〜4のアル
コキシ基を、R1は炭素数1〜10のアルキル基、炭素
数3〜8のシクロアルキル基、炭素数2〜10のアルケ
ニル基、炭素数2〜10のアルキニル基、フェニル基、
フェノキシ基、「ハロゲン原子、トリフルオロメチル
基、炭素数1〜6のアルキル基、炭素数1〜6のアルコ
キシ基」で置換されたフェニル基若しくはフェノキシ
基、あるいは−B−D(Bは炭素数1〜4のアルキレン
基を、Dはフェニル基、フェノキシ基、「ハロゲン原
子、トリフルオロメチル基、炭素数1〜6のアルキル
基、炭素数1〜6のアルコキシ基、フェニル基若しくは
フェノキシ基」で置換されたフェニル基若しくはフェノ
キシ基又は炭素数5〜7のシクロアルキル基を示す。)
で表される基を示し、Q′は水素原子又はZ′と同じ水
酸基の保護基である。X1及びX2はそれぞれ窒素原子、
酸素原子又はイオウ原子を示し、Z1はCO2y、C
N、OH、OCORz、CONRbc(Rb及びRcはそ
れぞれ水素原子、炭素数1〜6のアルキル基、炭素数1
〜6のアルコキシ基、ベンジル基又はフェニル基を示
す。)、水素原子、ハロゲン原子、又は置換若しくは無
置換の芳香族基より選ばれる基を示し、Ry及びRzはそ
れぞれ水素原子、炭素数1〜6のアルキル基又は炭素数
2〜6のアルケニル基を示し、lは1〜7の整数、m、
p及びrはそれぞれ0又は1の整数、n、q及びsはそ
れぞれ0〜5の整数を示す。
In the group represented by, T is CH 2 CH 2 or CH
A group selected from ═CH, j and k each independently represent an integer of 0, 1 or 2, and R 0 represents (2-k) hydrogen atoms, an alkyl group having 1 to 4 carbon atoms or 1 to 2 carbon atoms. 4 alkoxy group, R 1 is an alkyl group having 1 to 10 carbon atoms, a cycloalkyl group having 3 to 8 carbon atoms, an alkenyl group having 2 to 10 carbon atoms, an alkynyl group having 2 to 10 carbon atoms, a phenyl group,
Phenoxy group, phenyl group or phenoxy group substituted by "halogen atom, trifluoromethyl group, alkyl group having 1 to 6 carbon atoms, alkoxy group having 1 to 6 carbon atoms", or -BD (B is the number of carbon atoms 1 to 4 is an alkylene group, D is a phenyl group, a phenoxy group, "a halogen atom, a trifluoromethyl group, an alkyl group having 1 to 6 carbon atoms, an alkoxy group having 1 to 6 carbon atoms, a phenyl group or a phenoxy group". It represents a substituted phenyl group or phenoxy group or a cycloalkyl group having 5 to 7 carbon atoms.)
Wherein Q'is a hydrogen atom or the same hydroxyl group-protecting group as Z '. X 1 and X 2 are each a nitrogen atom,
Represents an oxygen atom or a sulfur atom, Z 1 is CO 2 R y , C
N, OH, OCOR z , CONR b R c (R b and R c are each a hydrogen atom, an alkyl group having 1 to 6 carbon atoms, and 1 carbon atom)
6 represents an alkoxy group, a benzyl group or a phenyl group. ), A hydrogen atom, a halogen atom, or a group selected from a substituted or unsubstituted aromatic group, R y and R z are each a hydrogen atom, an alkyl group having 1 to 6 carbon atoms or an alkenyl having 2 to 6 carbon atoms. Represents a group, l is an integer of 1 to 7, m,
p and r each represent an integer of 0 or 1, and n, q, and s each represent an integer of 0 to 5.

【0062】この場合、Q及びQ′の水酸基の保護基並
びに
In this case, the protective groups for the hydroxyl groups of Q and Q'and

【0063】[0063]

【化31】 [Chemical 31]

【0064】のR0、R1としては前記一般式〔I〕の
Z、Z′、R0及びR1で示したものと同様のものを例示
することができ、又このα,β−置換シクロペンタノン
誘導体〔III〕をプロスタグランジン類製造の中間体と
する場合には、上記
Examples of R 0 and R 1 are the same as those represented by Z, Z ′, R 0 and R 1 of the above-mentioned general formula [I]. When the cyclopentanone derivative [III] is used as an intermediate for the production of prostaglandins,

【0065】[0065]

【化32】 [Chemical 32]

【0066】基がThe base is

【0067】[0067]

【化33】 [Chemical 33]

【0068】(但し、式中R10、R11、Z′、(However, in the formula, R 10 , R 11 , Z ',

【0069】[0069]

【化34】 [Chemical 34]

【0070】は前記と同様の意味を示す)で表わされる
基であることが好ましい。
Is preferably the same as defined above).

【0071】上記置換シクロペンタノン誘導体〔I〕と
有機ラジカル前駆体〔II〕との反応において、有機ラジ
カル前駆体〔II〕は置換シクロペンタノン誘導体〔I〕
に対し0.5〜10当量、特に1〜5当量用いることが
好ましい。
In the reaction between the substituted cyclopentanone derivative [I] and the organic radical precursor [II], the organic radical precursor [II] is the substituted cyclopentanone derivative [I].
It is preferable to use 0.5 to 10 equivalents, especially 1 to 5 equivalents.

【0072】ラジカル発生剤は、ラジカル開始触媒とし
て用いるが、このラジカル発生剤としては、過酸化ベン
ゾイル、過酸化アセチル、t−ブチルヒドロペルオキシ
ド、クメンヒドロペルオキシド、ペルオキソ二硫酸カリ
ウム等の過酸化物、アゾビスイソブチロニトリル、アゾ
ビスシクロヘキサンカルボニトリル等のアゾ化合物ある
いはトリメチルボラン、トリエチルボラン、トリブチル
ボラン等のアルキルボラン化合物及び亜鉛粉末を銅塩又
はアンモニウム塩と超音波で処理したものを挙げること
ができる。
The radical generator is used as a radical initiation catalyst. Examples of the radical generator include peroxides such as benzoyl peroxide, acetyl peroxide, t-butyl hydroperoxide, cumene hydroperoxide and potassium peroxodisulfate. Examples include azo compounds such as azobisisobutyronitrile and azobiscyclohexanecarbonitrile, or alkylborane compounds such as trimethylborane, triethylborane and tributylborane, and zinc powder treated with a copper salt or ammonium salt and ultrasonic waves. it can.

【0073】ここでラジカル発生剤として過酸化物、ア
ゾ化合物、アルキルボラン化合物を用いる場合には、有
機ラジカル前駆体〔II〕に対して触媒量〜数当量、好ま
しくは0.05〜2当量用いる。更にラジカル性還元剤
として、トリブチルススヒドリド、トリフェニルスズヒ
ドリド、ジブチルスズヒドリド、ジフェニルスズヒドリ
ド等のスズヒドリド化合物を0〜過剰量、好ましくは1
〜5当量用いる。この場合の反応は、溶媒を用いて行う
ことができ、用いられる溶媒としては反応を阻害しない
ものであればよく、好ましくはベンゼン、トルエン、キ
シレンのようなベンゼン系溶媒、シクロヘキサン、ヘキ
サン、ペンタンのような炭化水素系溶媒及びそれらの混
合溶媒である。なお、反応温度は、通常−100℃〜溶
媒の還流温度、好ましくは−50〜100℃であり、特
にボラン化合物を用いる場合、低温でも反応が進行す
る。反応時間は通常10分〜24時間である。
When a peroxide, an azo compound or an alkylborane compound is used as the radical generator, it is used in a catalytic amount to several equivalents, preferably 0.05 to 2 equivalents, relative to the organic radical precursor [II]. . Further, as a radical reducing agent, a tin hydride compound such as tributyl sushydride, triphenyl tin hydride, dibutyl tin hydride or diphenyl tin hydride is used in 0 to excess amount, preferably 1
Use ~ 5 equivalents. The reaction in this case can be carried out using a solvent, and the solvent used may be one that does not inhibit the reaction, and is preferably benzene, toluene, a benzene solvent such as xylene, cyclohexane, hexane, or pentane. Such hydrocarbon-based solvents and mixed solvents thereof. The reaction temperature is generally -100 ° C to the reflux temperature of the solvent, preferably -50 to 100 ° C. Especially when a borane compound is used, the reaction proceeds even at a low temperature. The reaction time is usually 10 minutes to 24 hours.

【0074】さらに、ラジカル発生剤として亜鉛を用い
る場合には、亜鉛粉末を、ヨウ化銅、臭化銅、塩化銅の
ような銅塩、あるいは塩化アンモニウム、酢酸アンモニ
ウム、硫酸アンモニウム、塩化テトラメチルアンモニウ
ム、臭化テトラエチルアンモニウムのようなアンモニウ
ム塩と超音波等で処理することで、有機ラジカル前駆体
〔II〕と反応させることができる。有機ラジカル前駆体
〔II〕に対して過剰量の、好ましくは1〜5等量の亜鉛
と、触媒量の、好ましくは0.05〜2等量の銅塩ある
いはアンモニウム塩を用いる。反応溶媒としては、水、
メタノール、エタノール、イソプロパノール、ブタノー
ル等のアルコール類、エーテル、テトラヒドロフラン、
ジオキサン等のエーテル類、アセトニトリル、ジメチル
ホルムアミド、ジメチルスルホキシド等の極性溶媒又は
それらの混合溶媒を用いることができる。反応温度とし
ては、−20〜80℃、好ましくは、10〜25℃で、
反応時間は30分〜24時間である。
Further, when zinc is used as a radical generator, zinc powder is prepared from a copper salt such as copper iodide, copper bromide or copper chloride, or ammonium chloride, ammonium acetate, ammonium sulfate, tetramethylammonium chloride, The organic radical precursor [II] can be reacted by treating with an ammonium salt such as tetraethylammonium bromide and ultrasonic waves. An excess amount of zinc, preferably 1 to 5 equivalents, and a catalytic amount, preferably 0.05 to 2 equivalents, of copper salt or ammonium salt relative to the organic radical precursor [II] are used. As the reaction solvent, water,
Alcohols such as methanol, ethanol, isopropanol, butanol, ether, tetrahydrofuran,
An ether such as dioxane, a polar solvent such as acetonitrile, dimethylformamide, dimethylsulfoxide, or a mixed solvent thereof can be used. The reaction temperature is −20 to 80 ° C., preferably 10 to 25 ° C.,
The reaction time is 30 minutes to 24 hours.

【0075】なお、得られた反応生成物を加水分解する
必要がある場合、加水分解条件としては、通常の条件を
採用し得、例えばエステルの場合は水酸化ナトリウム、
水酸化リチウム、水酸化カリウム等の水酸化アルカリに
よる加水分解のほかに、加水分解酵素や微生物を用いる
方法が挙げられる。又、ニトリルを加水分解する場合や
水酸基の保護基をはずす場合には、上記のアルカリ加水
分解のほかに硫酸、塩酸、リン酸等の酸による加水分解
も採用される。
When it is necessary to hydrolyze the obtained reaction product, usual hydrolysis conditions can be adopted. For example, in the case of ester, sodium hydroxide,
In addition to hydrolysis with an alkali hydroxide such as lithium hydroxide or potassium hydroxide, a method using a hydrolase or a microorganism can be used. Further, in the case of hydrolyzing the nitrile or removing the protective group for the hydroxyl group, hydrolysis with an acid such as sulfuric acid, hydrochloric acid or phosphoric acid may be employed in addition to the above-mentioned alkaline hydrolysis.

【0076】[0076]

【発明の効果】本発明の製造法によれば、医薬品の中間
体、特にプロスタグランジン類の合成中間体として有用
なα,β−置換シクロペンタノン誘導体、特に下記式
〔IIIa〕
According to the production method of the present invention, an α, β-substituted cyclopentanone derivative useful as an intermediate for pharmaceuticals, particularly as a synthetic intermediate for prostaglandins, particularly the following formula [IIIa]

【0077】[0077]

【化35】 [Chemical 35]

【0078】(但し、式中Z、Z′、U、T、X1
2、Z1、R0、R1、R2、R3、R4、R5、R6、R7
8、R9、k、l、m、n、p、q、r及びsは前記と
同じ意味を示す。)で示される化合物を不安定なアニオ
ン試剤を調製したり、水分、酸素の混入を気にしたり有
毒な反応試剤を用いる等の不都合なく、中性の温和な条
件下で短工程で高収率に、即ち工業的有利に製造するこ
とができる。
(However, in the formula, Z, Z ', U, T, X 1 ,
X 2 , Z 1 , R 0 , R 1 , R 2 , R 3 , R 4 , R 5 , R 6 , R 7 ,
R 8 , R 9 , k, l, m, n, p, q, r and s have the same meanings as described above. ) The compound shown in) has no inconveniences such as preparing an unstable anion reagent, paying attention to contamination of water and oxygen, and using a toxic reaction reagent. That is, it can be manufactured industrially advantageously.

【0079】以下、実施例を挙げて本発明をより具体的
に説明するが、本発明は下記実施例に制限されるもので
はない。なお、下記例において、THFはテトラヒドロ
フラン、Meはメチル基、Etはエチル基、nBuはn
−ブチル基、tBuはt−ブチル基、TBSは tBuM
eSi基、AIBNはアゾビスイソブチロニトリルを示
す。
Hereinafter, the present invention will be described more specifically with reference to Examples, but the present invention is not limited to the following Examples. In the following examples, THF is tetrahydrofuran, Me is a methyl group, Et is an ethyl group, n Bu is n.
-Butyl group, t Bu is t-butyl group, TBS is t BuM
The eSi group and AIBN represent azobisisobutyronitrile.

【0080】[0080]

【実施例】【Example】

【0081】実施例1Example 1

【0082】[0082]

【化36】 [Chemical 36]

【0083】アルゴン雰囲気下、メチレンシクロペンタ
ノン(1)(465mg,1mmol)と6−ヨードヘ
キサン酸アリル(2)(1.14g,4mmol)のベ
ンゼン(10ml)溶液に、トリブチルスズヒドリド
(1.08ml,4mmol)とAIBN(8.2m
g,0.05mmol)を室温で加え、80℃に加熱し
て4時間撹拌した。室温に冷却後、反応液をシリカゲル
のショートカラムで濾過し、濾液を減圧濃縮した。 残
さをシリカゲルのカラムクロマトグラフィーで精製する
と、化合物(3)(368mg、収率61%)および化
合物(4)(72mg,収率12%)が得られた。
Tributyltin hydride (1.08 ml) was added to a solution of methylenecyclopentanone (1) (465 mg, 1 mmol) and allyl 6-iodohexanoate (2) (1.14 g, 4 mmol) in benzene (10 ml) under an argon atmosphere. , 4 mmol) and AIBN (8.2 m
g, 0.05 mmol) was added at room temperature, and the mixture was heated to 80 ° C. and stirred for 4 hours. After cooling to room temperature, the reaction solution was filtered through a silica gel short column, and the filtrate was concentrated under reduced pressure. The residue was purified by silica gel column chromatography to obtain compound (3) (368 mg, yield 61%) and compound (4) (72 mg, yield 12%).

【0084】化合物(3) 1 H-nmr(300MHz,CDCl3,δ):0.02(2s, 12H), 0.05(2s, 12
H), 0.87(2s, 18H), 0.89(2s, 18H), 0.70-1.00(m, 3
H), 1.02-1.81(m, 18H), 1.85-2.03(m, 1H), 2.08-2.25
(m, 3H), 2.44(dt, J=10.7, 7.2Hz, 1H), 2.63(dd, J=
6.9, 18.2Hz, 1H), 3.98-4.09(m, 1H), 4.11-4.25(m, 1
H), 4.63(d, J=5.0Hz, 2H), 5.15-5.40(m, 2H), 5.45-
5.64(m, 2H), 5.82(d, J=15.4Hz, 1H), 5.87-6.13(m, 1
H).13 C-nmr(75MHz,CDCl3):-4.71, -4.67, -4.6, -4.2, 14.
2, 18.0, 18.2, 20.0, 23.1, 25.8, 25.9, 26.4, 27.5,
28.2, 29.17, 29.23, 32.0, 36.9, 46.3, 47.5,53.2,
53.5, 64.7, 71.1, 73.2, 117.9, 121.0, 128.9, 132.
4, 136.3, 149.4,166.1, 215.7. IR(neat):775, 835, 1100, 1250, 1360, 1460, 1650, 1
725, 1740, 2855, 2930. [α]D 20 −40.3°(c=2.45,CHCl3
Compound (3) 1 H-nmr (300 MHz, CDCl 3 , δ): 0.02 (2s, 12H), 0.05 (2s, 12)
H), 0.87 (2s, 18H), 0.89 (2s, 18H), 0.70-1.00 (m, 3
H), 1.02-1.81 (m, 18H), 1.85-2.03 (m, 1H), 2.08-2.25
(m, 3H), 2.44 (dt, J = 10.7, 7.2Hz, 1H), 2.63 (dd, J =
6.9, 18.2Hz, 1H), 3.98-4.09 (m, 1H), 4.11-4.25 (m, 1
H), 4.63 (d, J = 5.0Hz, 2H), 5.15-5.40 (m, 2H), 5.45-
5.64 (m, 2H), 5.82 (d, J = 15.4Hz, 1H), 5.87-6.13 (m, 1
H). 13 C-nmr (75MHz, CDCl 3 ):-4.71, -4.67, -4.6, -4.2, 14.
2, 18.0, 18.2, 20.0, 23.1, 25.8, 25.9, 26.4, 27.5,
28.2, 29.17, 29.23, 32.0, 36.9, 46.3, 47.5, 53.2,
53.5, 64.7, 71.1, 73.2, 117.9, 121.0, 128.9, 132.
4, 136.3, 149.4, 166.1, 215.7.IR (neat): 775, 835, 1100, 1250, 1360, 1460, 1650, 1
725, 1740, 2855, 2930. [α] D 20 -40.3 ° (c = 2.45, CHCl 3 ).

【0085】化合物(4) 1 H-nmr(300MHz,CDCl3,δ):0.00(4s, 12H), 0.03(4s, 12
H), 0.06(4s, 12H), 0.08(4s, 12H), 0.87(2s, 18H),
0.88(2s, 18H), 0.80-0.96(m, 3H), 1.03-1.75(m,18H),
2.22(d, J=18.8Hz, 1H), 2.31(t, J=7.6Hz, 2H), 2.41
(dd, J=18.8, 5.1Hz, 1H), 2.56-2.66(m, 1H), 2.85-2.
94(m, 1H), 3.96-4.06(m, 1H), 4.20(d, J=5.2Hz, 1H),
4.57(dt, J=5.7, 1.4Hz, 1H), 5.07(dd, J=10.3, 15.1
Hz, 1H), 5.22(ddt, J=1.4, 10.4, 1.2Hz, 1H), 5.30(d
dt, J=1.5, 16.4, 1.5Hz, 1H), 5.58(dd, J=15.1, 6.6H
z, 1H), 5.92(ddt, J=10.4, 16.4, 5.7Hz, 1H).
Compound (4) 1 H-nmr (300 MHz, CDCl 3 , δ): 0.00 (4s, 12H), 0.03 (4s, 12)
H), 0.06 (4s, 12H), 0.08 (4s, 12H), 0.87 (2s, 18H),
0.88 (2s, 18H), 0.80-0.96 (m, 3H), 1.03-1.75 (m, 18H),
2.22 (d, J = 18.8Hz, 1H), 2.31 (t, J = 7.6Hz, 2H), 2.41
(dd, J = 18.8, 5.1Hz, 1H), 2.56-2.66 (m, 1H), 2.85-2.
94 (m, 1H), 3.96-4.06 (m, 1H), 4.20 (d, J = 5.2Hz, 1H),
4.57 (dt, J = 5.7, 1.4Hz, 1H), 5.07 (dd, J = 10.3, 15.1
Hz, 1H), 5.22 (ddt, J = 1.4, 10.4, 1.2Hz, 1H), 5.30 (d
dt, J = 1.5, 16.4, 1.5Hz, 1H), 5.58 (dd, J = 15.1, 6.6H
z, 1H), 5.92 (ddt, J = 10.4, 16.4, 5.7Hz, 1H).

【0086】実施例2 アルゴン雰囲気下、化合物(1)(465mg,1mm
ol)と化合物(2)(1.14g,4mmol)のト
ルエン(1ml)溶液に、0℃で、トリブチルスズヒド
リド(1.08ml,4mmol)とトリエチルボラン
(2Mヘキサン溶液,0.1mmol)を加え、0℃で
3時間撹拌した。実施例1と同様に処理することで、化
合物(3)と(4)の16.7:1(1H-nmrより算出)
の混合物410mg(収率68%)が得られた。
Example 2 Compound (1) (465 mg, 1 mm under an argon atmosphere)
ol) and the compound (2) (1.14 g, 4 mmol) in toluene (1 ml) at 0 ° C., tributyltin hydride (1.08 ml, 4 mmol) and triethylborane (2M hexane solution, 0.1 mmol) were added, Stirred at 0 ° C. for 3 hours. By treating in the same manner as in Example 1, 16.7: 1 of compounds (3) and (4) (calculated from 1 H-nmr).
410 mg (yield 68%) of the mixture was obtained.

【0087】実施例3 実施例2で、反応温度を20℃で行なうと、化合物
(3)と(4)の11.1:1の混合物416mg(収
率69%)が得られた。
Example 3 In Example 2, when the reaction temperature was 20 ° C., 416 mg (yield 69%) of a 11.1: 1 mixture of the compounds (3) and (4) was obtained.

【0088】実施例4 亜鉛粉末(584mg,8.93mmol)とヨウ化銅
(357mg,1.88mmol)のエタノール−水
(9:1,16.3ml)溶液を、5分間超音波処理し
た。この溶液に、化合物(1)(465mg,1mmo
l)と化合物(2)(1.14g,4mmol)のエタ
ノール−水(9:1,4ml)溶液を加え、18℃で6
時間超音波処理した。飽和食塩水(15ml)を加えエ
ーテルで抽出し、実施例1と同様に精製すると、化合物
(3)と(4)の10:1の混合物362mg(収率6
0%)が得られた。
Example 4 A solution of zinc powder (584 mg, 8.93 mmol) and copper iodide (357 mg, 1.88 mmol) in ethanol-water (9: 1, 16.3 ml) was sonicated for 5 minutes. In this solution, compound (1) (465 mg, 1 mmo
1) and a solution of the compound (2) (1.14 g, 4 mmol) in ethanol-water (9: 1, 4 ml) were added, and the mixture was added at 18 ° C for 6
Sonicated for hours. Saturated saline (15 ml) was added and the mixture was extracted with ether and purified in the same manner as in Example 1 to give 362 mg of a 10: 1 mixture of compounds (3) and (4) (yield 6
0%) was obtained.

【0089】実施例5Example 5

【0090】[0090]

【化37】 [Chemical 37]

【0091】実施例1と同様にして、化合物(1)と化
合物(5)から、化合物(6)(収率55%)と化合物
(7)(収率10%)が得られた。
In the same manner as in Example 1, compound (6) (yield 55%) and compound (7) (yield 10%) were obtained from compound (1) and compound (5).

【0092】化合物(6) 1 H-nmr(300MHz,CDCl3,δ):0.02(2s, 12H), 0.05(2s, 12
H), 0.87(2s, 18H), 0.89(2s, 18H), 0.82-0.95(m, 3
H), 1.17-1.68(m, 18H), 1.87-1.97(m, 1H), 2.17(dd,
J=8.2, 18.3Hz, 1H), 2.28(t, J=7.5Hz, 2H), 2.44(dt,
J=11.0, 7.5Hz, 1H), 2.62(ddd, J=18.3, 1.2, 6.9Hz,
1H), 3.66(s, 3H), 3.99-4.14(m, 2H), 5.50(dd, J=7.
7, 15.4Hz, 1H), 5.59(dd, J=15.4, 4.8Hz, 1H).13 C-nmr(75MHz,CDCl3):-4.6, -4.5, -4.2, 14.1, 18.1,
18.3, 22.7, 25.0, 25.1, 25.8, 25.9, 26.7, 27.8, 2
9.0, 29.5, 31.9, 34.1, 38.6, 47.6, 51.4, 53.3, 53.
9, 72.7, 128.7, 136.2, 174.0, 216.0. [α]D 21 −41.4°(c=2.60,CHCl3
Compound (6) 1 H-nmr (300 MHz, CDCl 3 , δ): 0.02 (2s, 12H), 0.05 (2s, 12)
H), 0.87 (2s, 18H), 0.89 (2s, 18H), 0.82-0.95 (m, 3
H), 1.17-1.68 (m, 18H), 1.87-1.97 (m, 1H), 2.17 (dd,
J = 8.2, 18.3Hz, 1H), 2.28 (t, J = 7.5Hz, 2H), 2.44 (dt,
J = 11.0, 7.5Hz, 1H), 2.62 (ddd, J = 18.3, 1.2, 6.9Hz,
1H), 3.66 (s, 3H), 3.99-4.14 (m, 2H), 5.50 (dd, J = 7.
7, 15.4Hz, 1H), 5.59 (dd, J = 15.4, 4.8Hz, 1H). 13 C-nmr (75MHz, CDCl 3 ):-4.6, -4.5, -4.2, 14.1, 18.1,
18.3, 22.7, 25.0, 25.1, 25.8, 25.9, 26.7, 27.8, 2
9.0, 29.5, 31.9, 34.1, 38.6, 47.6, 51.4, 53.3, 53.
9, 72.7, 128.7, 136.2, 174.0, 216.0. [Α] D 21 -41.4 ° (c = 2.60, CHCl 3 ).

【0093】化合物(7) 1 H-nmr(300MHz,CDCl3,δ):0.00(4s, 12H), 0.02(4s, 12
H), 0.06(4s, 12H), 0.09(4s, 12H), 0.87(2s, 18H),
0.88(2s, 18H), 0.82-0.97(m, 3H), 1.02-1.78(m,18H),
2.23(d, J=18.9Hz, 1H), 2.29(t, J=7.5Hz, 2H), 2.41
(dd, J=18.9, 5.1Hz, 1H), 2.56-2.66(m, 1H), 2.85-2.
95(m, 1H), 3.66(s, 3H), 3.97-4.05(m, 1H), 4.21(d,
J=5.3Hz, 1H), 5.07(dd, J=10.4, 15.0Hz, 1H), 5.59(d
d, J=15.0,6.3Hz, 1H).
Compound (7) 1 H-nmr (300 MHz, CDCl 3 , δ): 0.00 (4s, 12H), 0.02 (4s, 12)
H), 0.06 (4s, 12H), 0.09 (4s, 12H), 0.87 (2s, 18H),
0.88 (2s, 18H), 0.82-0.97 (m, 3H), 1.02-1.78 (m, 18H),
2.23 (d, J = 18.9Hz, 1H), 2.29 (t, J = 7.5Hz, 2H), 2.41
(dd, J = 18.9, 5.1Hz, 1H), 2.56-2.66 (m, 1H), 2.85-2.
95 (m, 1H), 3.66 (s, 3H), 3.97-4.05 (m, 1H), 4.21 (d,
J = 5.3Hz, 1H), 5.07 (dd, J = 10.4, 15.0Hz, 1H), 5.59 (d
d, J = 15.0, 6.3Hz, 1H).

【0094】実施例6Example 6

【0095】[0095]

【化38】 [Chemical 38]

【0096】実施例1と同様にして、化合物(1)と化
合物(8)から、化合物(9)と(10)の5:1の混
合物(収率50%)が得られた。
In the same manner as in Example 1, a 5: 1 mixture of compound (9) and compound (10) (yield 50%) was obtained from compound (1) and compound (8).

【0097】化合物(9) 1 H-nmr(300MHz,CDCl3,δ):0.02(3s, 12H), 0.05(3s, 12
H), 0.06(3s, 12H), 0.87(2s, 18H), 0.89(2s, 18H),
0.81-0.96(m, 3H), 1.15-1.68(m, 18H), 1.84-1.92(m,
1H), 2.17(dd, J=8.2, 18.4Hz, 1H), 2.32(t, J=7.4Hz,
2H), 2.44(dt, J=11.0, 7.7Hz, 1H), 2.62(ddd, J=18.
4, 1.1, 7.1Hz, 1H), 3.98-4.14(m, 2H), 5.50(dd, J=
7.2, 15.4Hz, 1H), 5.59(dd, J=15.4, 4.9Hz, 1H).13 C-nmr(75MHz,CDCl3):-4.6, -4.5, -4.2, 14.1, 18.1,
18.3, 22.7, 24.7, 25.1, 25.8, 26.0, 26.7, 27.8, 2
8.9, 29.5, 31.9, 34.0, 38.6, 47.6, 53.4, 53.9, 72.
7, 73.2, 128.7, 136.2, 179.4, 216.1.
Compound (9) 1 H-nmr (300 MHz, CDCl 3 , δ): 0.02 (3s, 12H), 0.05 (3s, 12)
H), 0.06 (3s, 12H), 0.87 (2s, 18H), 0.89 (2s, 18H),
0.81-0.96 (m, 3H), 1.15-1.68 (m, 18H), 1.84-1.92 (m,
1H), 2.17 (dd, J = 8.2, 18.4Hz, 1H), 2.32 (t, J = 7.4Hz,
2H), 2.44 (dt, J = 11.0, 7.7Hz, 1H), 2.62 (ddd, J = 18.
4, 1.1, 7.1Hz, 1H), 3.98-4.14 (m, 2H), 5.50 (dd, J =
7.2, 15.4Hz, 1H), 5.59 (dd, J = 15.4, 4.9Hz, 1H). 13 C-nmr (75MHz, CDCl 3 ):-4.6, -4.5, -4.2, 14.1, 18.1,
18.3, 22.7, 24.7, 25.1, 25.8, 26.0, 26.7, 27.8, 2
8.9, 29.5, 31.9, 34.0, 38.6, 47.6, 53.4, 53.9, 72.
7, 73.2, 128.7, 136.2, 179.4, 216.1.

【0098】実施例7 実施例4と同様にして、化合物(1)と化合物(8)か
ら、化合物(9)と(10)の10:1の混合物(収率
32%)が得られた。
Example 7 In the same manner as in Example 4, a 10: 1 mixture of compound (9) and (10) (yield 32%) was obtained from compound (1) and compound (8).

【0099】実施例8Example 8

【0100】[0100]

【化39】 [Chemical Formula 39]

【0101】実施例1と同様にして、化合物(1)と化
合物(11)から、化合物(12)(収率61%)と化
合物(13)(収率12%)が得られた。
In the same manner as in Example 1, compound (12) (yield 61%) and compound (13) (yield 12%) were obtained from compound (1) and compound (11).

【0102】化合物(12) 1 H-nmr(300MHz,CDCl3,δ):0.01(2s, 12H), 0.05(2s, 12
H), 0.87(2s, 18H), 0.89(2s, 18H), 0.80-0.95(m, 3
H), 1.14-1.80(m, 14H), 1.87-1.99(m, 1H), 2.17(dd,
J=8.2, 18.2Hz, 1H), 2.30(t, J=6.7Hz, 2H), 2.43(dt,
J=10.9, 7.6Hz, 1H), 2.63(dd, J=18.2, 6.8Hz, 1H),
3.74(s, 3H), 3.98-4.13(m, 2H), 5.50(dd,J=7.6, 15.4
Hz, 1H), 5.61(dd, J=15.4, 4.7Hz, 1H).13 C-nmr(75MHz,CDCl3):-4.7, -4.6, -4.3, 14.0, 18.0,
18.2, 18.5, 22.6, 25.1, 25.8, 25.9, 26.2, 27.3, 2
7.8, 31.8, 38.5, 47.5, 52.5, 53.5, 53.6, 72.6, 72.
9, 73.2, 89.5, 128.6, 136.5, 154.2, 215.9. [α]D 22 −36.0°(c=1.33,CHCl3
Compound (12) 1 H-nmr (300 MHz, CDCl 3 , δ): 0.01 (2s, 12H), 0.05 (2s, 12
H), 0.87 (2s, 18H), 0.89 (2s, 18H), 0.80-0.95 (m, 3
H), 1.14-1.80 (m, 14H), 1.87-1.99 (m, 1H), 2.17 (dd,
J = 8.2, 18.2Hz, 1H), 2.30 (t, J = 6.7Hz, 2H), 2.43 (dt,
J = 10.9, 7.6Hz, 1H), 2.63 (dd, J = 18.2, 6.8Hz, 1H),
3.74 (s, 3H), 3.98-4.13 (m, 2H), 5.50 (dd, J = 7.6, 15.4
Hz, 1H), 5.61 (dd, J = 15.4, 4.7Hz, 1H). 13 C-nmr (75MHz, CDCl 3 ):-4.7, -4.6, -4.3, 14.0, 18.0,
18.2, 18.5, 22.6, 25.1, 25.8, 25.9, 26.2, 27.3, 2
7.8, 31.8, 38.5, 47.5, 52.5, 53.5, 53.6, 72.6, 72.
9, 73.2, 89.5, 128.6, 136.5, 154.2, 215.9. [Α] D 22 −36.0 ° (c = 1.33, CHCl 3 )

【0103】化合物(13) 1 H-nmr(300MHz,CDCl3,δ):0.00(4s, 12H), 0.03(4s, 12
H), 0.06(4s, 12H), 0.09(4s, 12H), 0.87(2s, 18H),
0.89(2s, 18H), 0.75-0.95(m, 3H), 1.05-1.80(m,14H),
2.23(d, J=19.7Hz, 1H), 2.33(t, J=7.1Hz, 2H), 2.42
(dd, J=19.7, 5.1Hz, 1H), 2.56-2.68(m, 1H), 2.87-2.
96(m, 1H), 3.75(s, 3H), 3.98-4.07(m, 1H), 4.21(d,
J=5.6Hz, 1H), 5.07(dd, J=9.8, 14.9Hz, 1H), 5.61(d
d, J=14.9,7.1Hz, 1H).
Compound (13) 1 H-nmr (300MHz, CDCl 3 , δ): 0.00 (4s, 12H), 0.03 (4s, 12)
H), 0.06 (4s, 12H), 0.09 (4s, 12H), 0.87 (2s, 18H),
0.89 (2s, 18H), 0.75-0.95 (m, 3H), 1.05-1.80 (m, 14H),
2.23 (d, J = 19.7Hz, 1H), 2.33 (t, J = 7.1Hz, 2H), 2.42
(dd, J = 19.7, 5.1Hz, 1H), 2.56-2.68 (m, 1H), 2.87-2.
96 (m, 1H), 3.75 (s, 3H), 3.98-4.07 (m, 1H), 4.21 (d,
J = 5.6Hz, 1H), 5.07 (dd, J = 9.8, 14.9Hz, 1H), 5.61 (d
d, J = 14.9, 7.1Hz, 1H).

【0104】実施例9 実施例2と同様にして、化合物(1)と化合物(11)
から、化合物(12)と(13)の15.8:1の混合
物(収率70%)が得られた。
Example 9 Compound (1) and compound (11) were prepared in the same manner as in Example 2.
From the above, a 15.8: 1 mixture (yield 70%) of the compounds (12) and (13) was obtained.

【0105】実施例10 実施例3と同様にして、化合物(1)と化合物(11)
から、化合物(12)と(13)の10.8:1の混合
物(収率71%)が得られた。
Example 10 In the same manner as in Example 3, the compound (1) and the compound (11) were used.
From this, a 10.8: 1 mixture of compounds (12) and (13) (yield 71%) was obtained.

【0106】実施例11Example 11

【0107】[0107]

【化40】 [Chemical 40]

【0108】実施例1と同様にして、化合物(1)と化
合物(14)から、化合物(15)(収率65%)と化
合物(16)(収率10%)が得られた。
In the same manner as in Example 1, compound (15) (yield 65%) and compound (16) (yield 10%) were obtained from compound (1) and compound (14).

【0109】化合物(15) 1 H-nmr(300MHz,CDCl3,δ):0.00(2s, 12H), 0.04(2s, 12
H), 0.86(2s, 18H), 0.88(2s, 18H), 0.82-0.95(m, 3
H), 1.20-1.75(m, 12H), 1.90-1.99(m, 1H), 2.16(dd,
J=8.1, 18.2Hz, 1H), 2.44(dt, J=7.6, 11.0Hz, 1H),
2.55(t, J=6.6Hz, 2H), 2.61(dd, J=18.2, 7.1Hz, 1H),
3.38(t, J=6.0Hz, 2H), 3.65(t, J=6.6Hz, 2H), 3.67
(s, 3H), 4.00-4.12(m, 2H), 5.49(dd, J=7.7, 15.5Hz,
1H), 5.59(dd,J=4.9, 15.5Hz, 1H).13 C-nmr(75MHz,CDCl3):-4.7, -4.6, -4.3, 14.0, 18.0,
18.2, 22.6, 24.5, 25.0, 25.8, 25.9, 26.8, 31.8, 3
4.9, 38.5, 47.5, 51.6, 53.4, 53.5, 65.9, 71.0, 72.
6, 73.2, 128.6, 136.4, 172.0, 215.9. IR(neat):770, 830, 1110, 1250, 1360, 1460, 1740, 2
850, 2940. [α]D 23 −36.3°(c=3.65,CHCl3
Compound (15) 1 H-nmr (300MHz, CDCl 3 , δ): 0.00 (2s, 12H), 0.04 (2s, 12
H), 0.86 (2s, 18H), 0.88 (2s, 18H), 0.82-0.95 (m, 3
H), 1.20-1.75 (m, 12H), 1.90-1.99 (m, 1H), 2.16 (dd,
J = 8.1, 18.2Hz, 1H), 2.44 (dt, J = 7.6, 11.0Hz, 1H),
2.55 (t, J = 6.6Hz, 2H), 2.61 (dd, J = 18.2, 7.1Hz, 1H),
3.38 (t, J = 6.0Hz, 2H), 3.65 (t, J = 6.6Hz, 2H), 3.67
(s, 3H), 4.00-4.12 (m, 2H), 5.49 (dd, J = 7.7, 15.5Hz,
1H), 5.59 (dd, J = 4.9, 15.5Hz, 1H). 13 C-nmr (75MHz, CDCl 3 ):-4.7, -4.6, -4.3, 14.0, 18.0,
18.2, 22.6, 24.5, 25.0, 25.8, 25.9, 26.8, 31.8, 3
4.9, 38.5, 47.5, 51.6, 53.4, 53.5, 65.9, 71.0, 72.
6, 73.2, 128.6, 136.4, 172.0, 215.9.IR (neat): 770, 830, 1110, 1250, 1360, 1460, 1740, 2
850, 2940. [α] D 23 -36.3 ° (c = 3.65, CHCl 3)

【0110】化合物(16) 1 H-nmr(300MHz,CDCl3,δ):0.00(4s, 12H), 0.02(4s, 12
H), 0.06(4s, 12H), 0.08(4s, 12H), 0.87(s, 18H), 0.
80-0.97(m, 3H), 1.03-1.80(m, 12H), 2.21(d, J=19.2H
z, 1H), 2.41(dd, J=19.2, 5.2Hz, 1H), 2.57(t, J=6.6
Hz, 2H), 2.56-2.69(m, 1H), 2.86-2.95(m, 1H), 3.38
(t, J=6.8Hz, 1H), 3.66(t, J=6.6Hz, 1H),3.69(s, 3
H), 3.97-4.05(m, 1H), 4.20(d, J=5.6Hz, 1H), 5.07(d
d, J=10.3, 15.4Hz, 1H), 5.59(dd, J=15.4, 6.1Hz, 1
H).
Compound (16) 1 H-nmr (300 MHz, CDCl 3 , δ): 0.00 (4s, 12H), 0.02 (4s, 12)
H), 0.06 (4s, 12H), 0.08 (4s, 12H), 0.87 (s, 18H), 0.
80-0.97 (m, 3H), 1.03-1.80 (m, 12H), 2.21 (d, J = 19.2H
z, 1H), 2.41 (dd, J = 19.2, 5.2Hz, 1H), 2.57 (t, J = 6.6
Hz, 2H), 2.56-2.69 (m, 1H), 2.86-2.95 (m, 1H), 3.38
(t, J = 6.8Hz, 1H), 3.66 (t, J = 6.6Hz, 1H), 3.69 (s, 3
H), 3.97-4.05 (m, 1H), 4.20 (d, J = 5.6Hz, 1H), 5.07 (d
d, J = 10.3, 15.4Hz, 1H), 5.59 (dd, J = 15.4, 6.1Hz, 1
H).

【0111】実施例12 実施例2と同様にして、化合物(1)と化合物(14)
から、化合物(15)と(16)の14.2:1の混合
物(収率70%)が得られた。
Example 12 Compound (1) and compound (14) were prepared in the same manner as in Example 2.
Thus, a 14.2: 1 mixture (yield 70%) of the compounds (15) and (16) was obtained.

【0112】実施例13 実施例3と同様にして、化合物(1)と化合物(14)
から、化合物(15)と(16)の10.4:1の混合
物(収率65%)が得られた。
Example 13 Compound (1) and compound (14) were prepared in the same manner as in Example 3.
Thus, a 10.4: 1 mixture of compounds (15) and (16) (yield 65%) was obtained.

【0113】実施例14Example 14

【0114】[0114]

【化41】 [Chemical 41]

【0115】実施例1と同様にして、化合物(1)と化
合物(17)から、化合物(18)(収率33%)と化
合物(19)(収率9%)が得られた。
Compound (18) (yield 33%) and compound (19) (yield 9%) were obtained from compound (1) and compound (17) in the same manner as in Example 1.

【0116】化合物(18) 1 H-nmr(300MHz,CDCl3,δ):0.03(2s, 12H), 0.05(2s, 12
H), 0.87(2s, 18H), 0.90(2s, 18H), 0.80-0.94(m, 3
H), 1.20-1.80(m, 10H), 2.04-2.12(m, 1H), 2.19(dd,
J=8.2, 18.4Hz, 1H), 2.24-2.31(m, 1H), 2.38-2.53(m,
6H), 2.63(ddd, J=18.4, 1.1, 7.0Hz, 1H), 3.68(s, 3
H), 4.01-4.14(m, 2H), 5.51(dd, 7.9, 15.4Hz, 1H),
5.63(dd, J=5.0, 15.4Hz, 1H).13 C-nmr(75MHz,CDCl3):-4.7, -4.6, -4.3, 14.0, 14.7,
16.5, 18.0, 18.2, 22.6, 25.0, 25.8, 25.9, 27.5, 3
1.9, 33.8, 38.5, 47.4, 51.7, 52.3, 53.6, 72.6, 73.
2, 78.9, 80.2, 128.5, 136.6, 172.5, 215.7. IR(neat):770, 830, 1090, 1240, 1360, 1460, 1735, 2
320, 2850, 2930. [α]D 23 −46.0°(c=0.78,CHCl3
Compound (18) 1 H-nmr (300 MHz, CDCl 3 , δ): 0.03 (2s, 12H), 0.05 (2s, 12)
H), 0.87 (2s, 18H), 0.90 (2s, 18H), 0.80-0.94 (m, 3
H), 1.20-1.80 (m, 10H), 2.04-2.12 (m, 1H), 2.19 (dd,
J = 8.2, 18.4Hz, 1H), 2.24-2.31 (m, 1H), 2.38-2.53 (m,
6H), 2.63 (ddd, J = 18.4, 1.1, 7.0Hz, 1H), 3.68 (s, 3
H), 4.01-4.14 (m, 2H), 5.51 (dd, 7.9, 15.4Hz, 1H),
5.63 (dd, J = 5.0, 15.4Hz, 1H). 13 C-nmr (75MHz, CDCl 3 ):-4.7, -4.6, -4.3, 14.0, 14.7,
16.5, 18.0, 18.2, 22.6, 25.0, 25.8, 25.9, 27.5, 3
1.9, 33.8, 38.5, 47.4, 51.7, 52.3, 53.6, 72.6, 73.
2, 78.9, 80.2, 128.5, 136.6, 172.5, 215.7.IR (neat): 770, 830, 1090, 1240, 1360, 1460, 1735, 2
320, 2850, 2930. [α] D 23 −46.0 ° (c = 0.78, CHCl 3 ).

【0117】化合物(19) 1 H-nmr(300MHz,CDCl3,δ):0.00(4s, 12H), 0.02(4s, 12
H), 0.06(4s, 12H), 0.09(4s, 12H), 0.87(2s, 18H),
0.89(2s, 18H), 0.80-0.98(m, 3H), 1.05-1.60(m,8H),
2.25(d, J=17.3Hz, 1H), 2.35-2.55(m 7H), 2.85-2.98
(m, 2H), 3.68(s, 3H), 3.97-4.04(m, 1H), 4.21(d, J=
5.6Hz, 1H), 5.07(dd, J=8.4, 14.5Hz, 1H),5.50(dd, J
=14.5, 6.6Hz, 1H).
Compound (19) 1 H-nmr (300 MHz, CDCl 3 , δ): 0.00 (4s, 12H), 0.02 (4s, 12)
H), 0.06 (4s, 12H), 0.09 (4s, 12H), 0.87 (2s, 18H),
0.89 (2s, 18H), 0.80-0.98 (m, 3H), 1.05-1.60 (m, 8H),
2.25 (d, J = 17.3Hz, 1H), 2.35-2.55 (m 7H), 2.85-2.98
(m, 2H), 3.68 (s, 3H), 3.97-4.04 (m, 1H), 4.21 (d, J =
5.6Hz, 1H), 5.07 (dd, J = 8.4, 14.5Hz, 1H), 5.50 (dd, J
= 14.5, 6.6Hz, 1H).

【0118】実施例15 実施例3と同様にして、化合物(1)と化合物(17)
から、化合物(18)と(19)の10.1:1の混合
物(収率39%)が得られた。
Example 15 Compound (1) and compound (17) were prepared in the same manner as in Example 3.
From this, a 10.1: 1 mixture of compounds (18) and (19) (yield 39%) was obtained.

【0119】実施例16Example 16

【0120】[0120]

【化42】 [Chemical 42]

【0121】実施例1と同様にして、化合物(20)と
化合物(21)から、化合物(22)(収率60%)と
化合物(23)(収率12%)が得られた。
In the same manner as in Example 1, compound (22) (yield 60%) and compound (23) (yield 12%) were obtained from compound (20) and compound (21).

【0122】化合物(22) 1 H-nmr(300MHz,CDCl3,δ):0.02(4s, 12H), 0.04(4s, 12
H), 0.05(4s, 12H), 0.06(4s, 12H), 0.87(2s, 18H),
0.89(2s, 18H), 0.75-0.97(m, 6H), 1.00-1.80(m,15H),
1.87-2.00(m, 1H), 2.08-2.24(m, 3H), 2.44(dt, J=1
0.9, 7.1Hz, 1H),2.62(ddd, J=1.1, 6.9, 18.2Hz, 1H),
3.98-4.09(m, 1H), 4.13-4.22(m, 1H), 4.62(dt, J=5.
6, 1.4Hz, 2H), 5.23(ddt, J=1.3, 10.4, 1.2Hz, 1H),
5.32(ddt,J=1.6, 17.2, 1.5Hz, 1H), 5.50(dd, J=6.5,
15.4Hz, 1H), 5.57(dd, J=15.4, 5.2Hz, 1H), 5.82(dt,
J=15.6, 1.5Hz, 1H), 5.93(ddt, 10.4, 17.2, 5.6Hz,
1H), 6.96(dt, J=15.6, 6.9Hz, 1H).13 C-nmr(75MHz,CDCl3):-4.6, -4.5, -4.1, 14.2, 18.1,
20.1, 23.1, 25.8, 26.0, 26.5, 27.7, 28.3, 29.2, 2
9.3, 32.1, 36.9, 46.3, 47.6, 53.3, 53.6, 64.9, 71.
1, 73.3, 117.9, 120.9, 128.8, 132.3, 136.2, 149.4,
166.1, 215.8. [α]D 20 −34.2°(c=3.50,CHCl3
Compound (22) 1 H-nmr (300 MHz, CDCl 3 , δ): 0.02 (4s, 12H), 0.04 (4s, 12)
H), 0.05 (4s, 12H), 0.06 (4s, 12H), 0.87 (2s, 18H),
0.89 (2s, 18H), 0.75-0.97 (m, 6H), 1.00-1.80 (m, 15H),
1.87-2.00 (m, 1H), 2.08-2.24 (m, 3H), 2.44 (dt, J = 1
0.9, 7.1Hz, 1H), 2.62 (ddd, J = 1.1, 6.9, 18.2Hz, 1H),
3.98-4.09 (m, 1H), 4.13-4.22 (m, 1H), 4.62 (dt, J = 5.
6, 1.4Hz, 2H), 5.23 (ddt, J = 1.3, 10.4, 1.2Hz, 1H),
5.32 (ddt, J = 1.6, 17.2, 1.5Hz, 1H), 5.50 (dd, J = 6.5,
15.4Hz, 1H), 5.57 (dd, J = 15.4, 5.2Hz, 1H), 5.82 (dt,
J = 15.6, 1.5Hz, 1H), 5.93 (ddt, 10.4, 17.2, 5.6Hz,
1H), 6.96 (dt, J = 15.6, 6.9Hz, 1H). 13 C-nmr (75MHz, CDCl 3 ):-4.6, -4.5, -4.1, 14.2, 18.1,
20.1, 23.1, 25.8, 26.0, 26.5, 27.7, 28.3, 29.2, 2
9.3, 32.1, 36.9, 46.3, 47.6, 53.3, 53.6, 64.9, 71.
1, 73.3, 117.9, 120.9, 128.8, 132.3, 136.2, 149.4,
166.1, 215.8. [Α] D 20 −34.2 ° (c = 3.50, CHCl 3 ).

【0123】化合物(23) 1 H-nmr(300MHz,CDCl3,δ):0.00(4s, 12H), 0.02(4s, 12
H), 0.06(4s, 12H), 0.08(4s, 12H), 0.87(2s, 18H),
0.89(2s, 18H), 0.78-0.95(m, 15H), 2.12-2.28(m,3H),
2.41(dd, J=4.7, 19.1Hz, 1H), 2.56-2.68(m 1H), 2.8
6-2.94(m, 1H), 4.00-4.14(m, 1H), 4.21(d, J=5.1Hz,
1H), 4.63(d, J=5.6Hz, 2H), 5.07(dd, J=10.3, 15.4H
z, 1H), 5.24(d, J=10.3Hz, 1H), 5.32(d, J=16.4Hz, 1
H), 5.57(dd,J=15.4, 7.5Hz, 1H), 5.83(d, J=15.6Hz,
1H), 5.95(ddt, J=10.3, 16.4, 5.6Hz, 1H), 6.97(dt,
J=15.6, 5.6Hz, 1H).
Compound (23) 1 H-nmr (300MHz, CDCl 3 , δ): 0.00 (4s, 12H), 0.02 (4s, 12)
H), 0.06 (4s, 12H), 0.08 (4s, 12H), 0.87 (2s, 18H),
0.89 (2s, 18H), 0.78-0.95 (m, 15H), 2.12-2.28 (m, 3H),
2.41 (dd, J = 4.7, 19.1Hz, 1H), 2.56-2.68 (m 1H), 2.8
6-2.94 (m, 1H), 4.00-4.14 (m, 1H), 4.21 (d, J = 5.1Hz,
1H), 4.63 (d, J = 5.6Hz, 2H), 5.07 (dd, J = 10.3, 15.4H
z, 1H), 5.24 (d, J = 10.3Hz, 1H), 5.32 (d, J = 16.4Hz, 1
H), 5.57 (dd, J = 15.4, 7.5Hz, 1H), 5.83 (d, J = 15.6Hz,
1H), 5.95 (ddt, J = 10.3, 16.4, 5.6Hz, 1H), 6.97 (dt,
J = 15.6, 5.6Hz, 1H).

【0124】実施例17 実施例2と同様にして、化合物(20)と化合物(2
1)から、化合物(22)と(23)の14.7:1の
混合物(収率65%)が得られた。
Example 17 In the same manner as in Example 2, the compound (20) and the compound (2
From 1), a 14.7: 1 mixture (yield 65%) of the compounds (22) and (23) was obtained.

【0125】実施例18 実施例3と同様にして、化合物(20)と化合物(2
1)から、化合物(22)と(23)の9.6:1の混
合物(収率70%)が得られた。
Example 18 In the same manner as in Example 3, the compound (20) and the compound (2
From 1), a 9.6: 1 mixture (yield 70%) of the compounds (22) and (23) was obtained.

【0126】実施例19Example 19

【0127】[0127]

【化43】 [Chemical 43]

【0128】実施例1と同様にして、化合物(24)と
化合物(5)から、化合物(25)(収率64%)と化
合物(26)(収率14%)が得られた。
In the same manner as in Example 1, compound (25) (yield 64%) and compound (26) (yield 14%) were obtained from compound (24) and compound (5).

【0129】化合物(25) 1 H-nmr(300MHz,CDCl3,δ):0.04(2s, 15H), 0.10(2s, 15
H), 0.87(s, 9H), 0.92(t, J=7.1Hz, 3H), 1.16(2s, 3
H), 1.17(2s, 3H), 1.15-1.69(m, 16H), 1.86-1.99(m,
1H), 2.12-2.32(m, 3H), 2.26(t, J=7.5Hz, 2H), 2.35-
2.47(m, 1H), 2.55-2.67(m, 1H), 3.66(s, 3H), 3.95-
4.06(m, 1H), 5.25-5.37(m, 1H), 5.52-5.69(m, 1H).
Compound (25) 1 H-nmr (300 MHz, CDCl 3 , δ): 0.04 (2s, 15H), 0.10 (2s, 15)
H), 0.87 (s, 9H), 0.92 (t, J = 7.1Hz, 3H), 1.16 (2s, 3
H), 1.17 (2s, 3H), 1.15-1.69 (m, 16H), 1.86-1.99 (m,
1H), 2.12-2.32 (m, 3H), 2.26 (t, J = 7.5Hz, 2H), 2.35-
2.47 (m, 1H), 2.55-2.67 (m, 1H), 3.66 (s, 3H), 3.95-
4.06 (m, 1H), 5.25-5.37 (m, 1H), 5.52-5.69 (m, 1H).

Claims (4)

【特許請求の範囲】[Claims] 【請求項1】 一般式〔I〕 【化1】 〔但し、式中Xは(α−OZ,β−H)又は(α−H,
β−OZ)を示し、Zは水酸基の保護基を示す。又、Y
は(α−H,β−R)又は(α−R,β−H)を示し、
Rは 【化2】 で示される基で、TはCH2CH2又はCH=CHより選
ばれる基を、j及びkはそれぞれ独立に0、1又は2の
整数を、R0は(2−k)個の水素原子、炭素数1〜4
のアルキル基又は炭素数1〜4のアルコキシ基を、R1
は炭素数1〜10のアルキル基、炭素数3〜8のシクロ
アルキル基、炭素数2〜10のアルケニル基、炭素数2
〜10のアルキニル基、フェニル基、フェノキシ基、
「ハロゲン原子、トリフルオロメチル基、炭素数1〜6
のアルキル基、炭素数1〜6のアルコキシ基」で置換さ
れたフェニル基若しくはフェノキシ基、あるいは−B−
D(Bは炭素数1〜4のアルキレン基を、Dはフェニル
基、フェノキシ基、「ハロゲン原子、トリフルオロメチ
ル基、炭素数1〜6のアルキル基、炭素数1〜6のアル
コキシ基、フェニル基若しくはフェノキシ基」で置換さ
れたフェニル基若しくはフェノキシ基又は炭素数5〜7
のシクロアルキル基を示す。)で表される基を示し、
Z′は上記Zと同種又は異種の水酸基の保護基を示
す。〕で表される置換シクロペンタノン誘導体と、一般
式〔II〕 A(CR23)l1 m(CR45)np(CR67)q2 r(CR89)s1 〔II〕 〔但し、式中、Aはハロゲン原子又は 【化3】 (RXは水素原子、炭素数1〜9のアルキル基、アラル
キル基又はアリール基を表す。)を示し、R2、R3、R
4、R5、R6、R7及びR8はそれぞれ独立に水素原子、
炭素数1〜4のアルキル基又は炭素数1〜4のアルコキ
シ基を示し、R9は水素原子、炭素数1〜6のアルキル
基、炭素数1〜6のアルコキシ基、ハロゲン原子、C
N、NH2、OH又は−COORa(Raは水素原子、炭
素数1〜6のアルキル基又は炭素数2〜6のアルケニル
基を示す)を、UはCH2CH2 、CH=CH、C≡
C、C=C=C又はフェニレン基より選ばれる基を示
し、lは1〜7の整数、m、p及びrはそれぞれ0又は
1の整数、n、q及びsはそれぞれ0〜5の整数を示
す。X1及びX2はそれぞれ酸素原子又はイオウ原子を示
し、Z1はCO2y、CN、OH、OCORz、CONR
bc(Rb及びRcはそれぞれ水素原子、炭素数1〜6の
アルキル基、炭素数1〜6のアルコキシ基、ベンジル基
又はフェニル基を示す。)、水素原子、ハロゲン原子、
又は置換若しくは無置換の芳香族基より選ばれる基を示
し、Ry及びRzはそれぞれ水素原子、炭素数1〜6のア
ルキル基又は炭素数2〜6のアルケニル基を示す。〕で
表わされる有機ラジカル前駆体とを、ラジカル発生剤の
存在下で反応させ、所望により加水分解することを特徴
とする一般式〔III〕 【化4】 〔但し、式中Wは(α−OQ,β−H)又は(α−H,
β−OQ)を示し、Qは水素原子又はZと同じ水酸基の
保護基を示す。又、Vは(α−H,β−R)又は(α−
R,β−H)を示し、Rは 【化5】 で示される基で、T、R0、j及びkは前記と同じ意味
を示し、Q′は水素原子又はZ′と同じ水酸基の保護基
を示す。又、X1、X2、U、R2、R3、R4、R5
6、R7、R8、R9、Z1、l、m、n、p、q、r及
びsは前記と同じ意味を示す。〕で表わされるα,β−
置換シクロペンタノン誘導体の製造法。
1. A compound represented by the general formula [I]: [Wherein X is (α-OZ, β-H) or (α-H,
β-OZ), and Z represents a hydroxyl-protecting group. Also, Y
Represents (α-H, β-R) or (α-R, β-H),
R is In the group represented by, T is a group selected from CH 2 CH 2 or CH═CH, j and k are each independently an integer of 0, 1 or 2, and R 0 is (2-k) hydrogen atoms. , Carbon number 1-4
The alkyl group or the alkoxy group having 1 to 4 carbon atoms of R 1
Is an alkyl group having 1 to 10 carbon atoms, a cycloalkyl group having 3 to 8 carbon atoms, an alkenyl group having 2 to 10 carbon atoms, and 2 carbon atoms
Alkynyl group, phenyl group, phenoxy group,
"Halogen atom, trifluoromethyl group, carbon number 1-6
Alkyl group, C1-C6 alkoxy group "substituted phenyl group or phenoxy group, or -B-
D (B is an alkylene group having 1 to 4 carbon atoms, D is a phenyl group, a phenoxy group, "a halogen atom, a trifluoromethyl group, an alkyl group having 1 to 6 carbon atoms, an alkoxy group having 1 to 6 carbon atoms, phenyl Group or phenoxy group "substituted with a phenyl group or a phenoxy group or a carbon number of 5 to 7
Represents a cycloalkyl group. ) Represents a group represented by
Z'represents a protective group for a hydroxyl group which is the same as or different from Z described above. ] And substituted cyclopentanone derivative represented by the general formula [II] A (CR 2 R 3) l X 1 m (CR 4 R 5) n U p (CR 6 R 7) q X 2 r (CR 8 R 9 ) s Z 1 [II] [wherein A is a halogen atom or (R X represents a hydrogen atom, an alkyl group having 1 to 9 carbon atoms, an aralkyl group or an aryl group), and R 2 , R 3 and R
4 , R 5 , R 6 , R 7 and R 8 are each independently a hydrogen atom,
R 9 represents an alkyl group having 1 to 4 carbon atoms or an alkoxy group having 1 to 4 carbon atoms, R 9 represents a hydrogen atom, an alkyl group having 1 to 6 carbon atoms, an alkoxy group having 1 to 6 carbon atoms, a halogen atom, C
N, NH 2 , OH or —COOR a (R a represents a hydrogen atom, an alkyl group having 1 to 6 carbon atoms or an alkenyl group having 2 to 6 carbon atoms), U is CH 2 CH 2 , CH═CH, C≡
C, C = C = C or a group selected from phenylene groups, l is an integer of 1 to 7, m, p and r are each an integer of 0 or 1, n, q and s are each an integer of 0 to 5 Indicates. X 1 and X 2 each represent an oxygen atom or a sulfur atom, and Z 1 represents CO 2 R y , CN, OH, OCOR z , CONR.
b R c (R b and R c each represent a hydrogen atom, an alkyl group having 1 to 6 carbon atoms, an alkoxy group having 1 to 6 carbon atoms, a benzyl group or a phenyl group), a hydrogen atom, a halogen atom,
Or a group selected from a substituted or unsubstituted aromatic group, R y and R z each represents a hydrogen atom, an alkyl group having 1 to 6 carbon atoms or an alkenyl group having 2 to 6 carbon atoms. ] An organic radical precursor represented by the formula] is reacted in the presence of a radical generator and optionally hydrolyzed. [Wherein W is (α-OQ, β-H) or (α-H,
β-OQ), and Q represents a hydrogen atom or the same hydroxyl-protecting group as Z. V is (α-H, β-R) or (α-
R, β-H), where R is In the group represented by, T, R 0 , j and k have the same meanings as described above, and Q ′ represents a hydrogen atom or the same hydroxyl group-protecting group as Z ′. Also, X 1 , X 2 , U, R 2 , R 3 , R 4 , R 5 ,
R 6 , R 7 , R 8 , R 9 , Z 1 , l, m, n, p, q, r and s have the same meanings as described above. ], Α-β-
A method for producing a substituted cyclopentanone derivative.
【請求項2】 ラジカル発生剤が、過酸化物、アゾ化合
物又はアルキルボラン化合物である請求項1記載の製造
法。
2. The method according to claim 1, wherein the radical generator is a peroxide, an azo compound or an alkylborane compound.
【請求項3】 ラジカル発生剤と共にさらに水素化スズ
化合物を用いて反応させることを特徴とする請求項2記
載の製造法。
3. The method according to claim 2, wherein the reaction is further carried out by using a tin hydride compound together with the radical generator.
【請求項4】 ラジカル発生剤が、亜鉛を銅塩又はアン
モニウム塩と超音波で処理したものである請求項1記載
の製造法。
4. The method according to claim 1, wherein the radical generator is zinc treated with a copper salt or an ammonium salt by ultrasonic waves.
JP05483393A 1993-02-19 1993-02-19 Process for producing α, β-substituted cyclopentanone derivatives Expired - Fee Related JP3304477B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP05483393A JP3304477B2 (en) 1993-02-19 1993-02-19 Process for producing α, β-substituted cyclopentanone derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP05483393A JP3304477B2 (en) 1993-02-19 1993-02-19 Process for producing α, β-substituted cyclopentanone derivatives

Publications (2)

Publication Number Publication Date
JPH06247928A true JPH06247928A (en) 1994-09-06
JP3304477B2 JP3304477B2 (en) 2002-07-22

Family

ID=12981645

Family Applications (1)

Application Number Title Priority Date Filing Date
JP05483393A Expired - Fee Related JP3304477B2 (en) 1993-02-19 1993-02-19 Process for producing α, β-substituted cyclopentanone derivatives

Country Status (1)

Country Link
JP (1) JP3304477B2 (en)

Also Published As

Publication number Publication date
JP3304477B2 (en) 2002-07-22

Similar Documents

Publication Publication Date Title
JP3233403B2 (en) Optically active intermediate and method for producing the same
JP4440506B2 (en) Chemical process
KR20040084915A (en) Novel boronate esters
JP3304477B2 (en) Process for producing α, β-substituted cyclopentanone derivatives
US5618959A (en) Process for preparing prostaglandin E1, E2 and analogs thereof using furylcopper reagents
JPH04149151A (en) Production of 4-bromo-3-hydroxybutyric acid ester derivative
JP2917552B2 (en) Method for producing α-methylenecyclopentanone derivative
CH648821A5 (en) PROCESSES FOR THE PREPARATION OF TETRA-SUBSTITUTED CYCLOPROPANIC DERIVATIVES.
JP3446225B2 (en) Cyclopentane derivative and method for producing the same
US6632958B1 (en) Process for producing a purified prostaglandin derivative
JPH07252276A (en) Organotin compound, its production and production of alpha-substituted cyclopentenone derivative
JPH10306053A (en) Production of ester
JP4041928B2 (en) Diene compound and method for producing the same
JPH04124157A (en) Production of optically active 4-chloro-3-hydroxybutanoic acid and its ester
KR20250050531A (en) Method for producing Tafluprost
JPH01228930A (en) Diastereoselective production of 3-substituted-1-cyclopentenol derivative
JPH0474152A (en) Production of alpha,beta-substituted cyclopentanone derivative
JPH05271148A (en) Production of optically active alpha-hydrocarboxylic acid
JPH07233175A (en) Asymmetric production of metal-substituted cyclopropylmethanol derivative.
JPH0362706B2 (en)
JPH09169780A (en) Production of 3-chloro-4-silyloxy-2-cyclopenten-1-one compound
JPH0313225B2 (en)
JPS61254537A (en) γ-Fluoro-α-hydroxycarboxylic acid derivative and method for producing the same
JPH07242577A (en) Optically active cyclopropane derivative
WO1995033707A1 (en) Process for producing 4-oxo-2-alkenoic ester

Legal Events

Date Code Title Description
FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090510

Year of fee payment: 7

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20090510

Year of fee payment: 7

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20100510

Year of fee payment: 8

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20110510

Year of fee payment: 9

FPAY Renewal fee payment (prs date is renewal date of database)

Free format text: PAYMENT UNTIL: 20120510

Year of fee payment: 10

LAPS Cancellation because of no payment of annual fees